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ABSTRACT 
 
Flavonoids, one of the biggest classes of secondary metabolites, are found abundantly in 
nature in a broad range of fruits, vegetables and beverages such as tea, coffee, beer, wine 
and fruit drinks. Flavonoids have been reported to exert multiple biological functions as 
well as tremendous pharmacological activity, including anticancer activity, protection, 
antioxidant activity, cardiovascular protection, antibacterial, antifungal and antiviral 
activity. The antioxidant activity of flavones is reported to be associated with those bearing 
hydroxyl functions.  
In the present study, several reaction steps have been carried out to synthesize three sub 
classes of flavonoids namely; chalcones, dihydrochalcones and flavanones with various 
substituents attached. The first step involved protection of hydroxyl groups of 
acetophenone and benaldehyde as starting materials. Thereafter the Clasien Schmidt 
condensation reaction, under basic conditions, was performed to afford chalcone 
intermediates. Treatment of these chalcones with sodium acetate, under reflux, afforded 
flavanones as a single product in high yields. Thereafter all protecting groups where 
removed to yield the final products. All products and intermediates where purified by 
column chromatography and were characterized by Nuclear Magnetic Resonance 
Spectroscopy (NMR) (1H NMR and 13C  NMR). 
An electrochemical analysis on all flavonoid compounds was performed by Cyclic 
Voltammetry (CV) and Square Wave Voltammetry (SWV) to give information on the 
accessible redox couples identified by their oxidation potentials. Oxidation potentials, 
which gave valuable information about reducing ability and hence the antioxidant activity, 
where used to compare all compounds. The antioxidant activity was observed to increase 
with the addition of hydroxyl groups on the B-ring. Compounds with a combination of 
hydroxyl groups on the A-ring and methoxy groups on the B-ring showed increased 
antioxidant activity when compared to those with only hydroxyl groups on the base 
structure. 2, 5, 4’-trihydroxy dihydrochalcone showed moderate antioxidant ability. 
However the 2, 5, 4’-trihydroxychalcone, containing the α, β unsaturated double bond, 
proved to have the greatest antioxidant ability. 
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Chapter 1: Introduction 
1 
CHAPTER 1 
 
1. INTRODUCTION AND OBJECTIVES  
 
1.1 Introduction 
The term “flavonoid”, derived from the Latin word “flavus” meaning Yellow, is used to 
describe a broad collection of naturally occurring polyphenolic compounds having a  
C6-C3-C6 skeleton structure consisting of two aromatic rings (A and B) and a heterocyclic 
ring (C) (Figure 1.1). These compounds, which are one of the biggest classes of secondary 
metabolites [1], are found abundantly in nature in a broad range of fruits, vegetables and 
beverages such as tea, coffee, beer, wine and fruit drinks. 
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Figure 1.1: Basic skeleton of flavonoids 
 
Over 8000 different naturally occurring flavonoids have been discovered [2] and the list is 
still growing. Most of these structurally different flavonoids can be subdivided into several 
classes of compounds, based on the degree of saturation present on the heterocyclic C-ring; 
they include the dihydrochalcone (1), chalcone (2), flavanone (3), flavone (4), isoflavone 
(5) and Flavanol (6) (Figure 1.2) [3]. 
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Figure 1.2: Flavonoid groups 
 
Flavonoids are considered to be one of the most important natural products around the 
world and have aroused considerable interest in recent years due to their therapeutic effects 
on human health. Flavonoids and its derivatives, have reported to exert multiple biological 
and pharmacological activity including antimicrobial, anti-inflammatory, analgesic, 
antimalarial, antioxidant, antibacterial, antibiotic, immunomodulatory as well as antitumor 
activity [4 -13]. It has also been reported that flavonoids and its derivatives have proven to 
be important intermediates in the synthesis of antiviral HIV-1 drugs  
[14-15]. The expected antioxidant ability of these compounds is attributed to the 
conjugated double bonds and completely delocalized π-electron system on both benzene 
rings, which is why they are increasingly thought to be responsible for the longer life 
expectancy of populations with well-balanced, healthy diets [16 – 17]. Such a diet consists 
of a high amount of fruits and vegetables as well as beverages from vegetable origin. 
Among compounds of known structure, flavanoids and flavonoids deserve special attention 
because they are present in large amounts in practically all-dietary plants, fruits and roots, 
and are consumed daily in substantial amounts. 
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1.1.1 Synthesis of Chalcones and Flavanones 
The tremendous biological properties and antioxidant activity of flavonoids has resulted in 
intense synthetic efforts towards their synthesis. Chalcones (2), also found abundantly in 
edible plants, are well known intermediates in the metabolic pathway as well as the 
chemical synthesis of Flavanoids [18]. They have a general chemical structure of two 
phenyl groups, both containing hydroxyl groups, connected by a three carbon α,β 
unsaturated carbonyl system [(-C=C-(CO)-]. Chalcones (9) are readily accessible via two 
well-established synthetic routes comprising of a base-catalyzed aldol/Claisen Schmidt 
condensation or acid-mediated aldolization of equimolar o-hydroxyacetophenones (7) and 
benzaldehydes (8) [19].Cyclization of the o-hydroxychalcones, a fundamental step in 
biosynthesis of flavonoids [20], is achieved through an intermolecular reaction, under basic 
or acidic conditions, to produce the corresponding flavanone (10) Scheme (1.1). This 
reaction produces the chromane core that is characteristic of many flavonoids.  
 
 
O
CH3
OH
H
O
+
BASE
O
OH
OH
O
O
O
OH
-H2O
ACID / BASE
(7)  o  Hydroxyactophenone (8)  Benzaldehyde
(9)  Chalcone(10)  Flavanone  
 
Scheme 1.1: Claisen Schmidt condensation of 2’-hydroxyacetophenone and 
benzaldehyde, followed by aldol condensation. 
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1.1.2 Radicals and Antioxidants  
1.1.2.1 Free radicals 
Radicals, often referred to as ‘free radicals’, are described as atoms, molecules or ions with 
unpaired electrons in an open shell configuration and are formed by single electron 
oxidation or reduction. Their formation is associated with the natural metabolism of 
aerobic cells whereby the oxygen consumption, inherent to cell growth, leads to the 
generation of free radicals. Examples of these reactive oxygen species (ROS) include 
superoxide, peroxyl, alkoxyl, hydroxyl and nitric oxide. Free radicals play an important 
role in cellular energy producing systems and the synthesis of biological compounds, 
however if they are produced in excess, they could attack lipid in the cell membranes, 
proteins, enzymes and DNA. These oxidative damages can lead to aging and several 
degenerative diseases such as cancer, stroke, myocardial infarction and diabetes [21-23]. 
Many forms of cancer are believed to be the result of reactions between free radicals and 
DNA, resulting in mutations that can affect the cell cycle and potentially lead to 
malignancy. Termination of these free radicals occurs through enzymatic means or by free 
radical scavenging by antioxidants; therefore antioxidants play a key role in these defence 
mechanisms [24]. 
 
1.1.2.2 Antioxidants 
Oxidation reactions are crucial for life; however they can also damage or kill cells. An 
antioxidant is a molecule that inhibits oxidation reactions, therefore preventing the 
formation of free radical intermediates, and diminishing its undesired effect. The radical 
scavenging is achieved by being oxidized themselves and therefore antioxidants are often 
found to be reducing agents such as thiols, ascorbic acid, or polyphenols. Due to their 
cellular protective abilities, antioxidants are widely used in dietary supplements and have 
been investigated for the prevention of diseases such as cancer, coronary heart disease and 
many others linked to oxidative stress [25]. 
 
1.1.3 Antioxidant activity and Electrochemistry of Flavonoids 
1.1.3.1 Antioxidant Activity of Flavonoids 
Polyphenolic compounds such as chalcones, flavonoids and prenylated flavanoids have 
shown to have tremendous radical scavenging ability and are therefore regarded as 
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excellent antioxidants [26, 27]. The radical scavenging within the flavonoid system is said 
to occur via an electron transfer process, in which the phenol is transformed into a 
phenoxyl radical resulting in the formation of the semiquinone (Scheme 1.2) [28]. 
Therefore flavonoids can be described as hydrogen donating antioxidants due to the 
reducing properties of the multiple hydroxyl groups attached to aromatic ring systems, 
along with their ability to delocalize the resulting phenoxyl radical within the structure 
[29].Various structural parameters such as aromatic hydroxyl groups, the catechol group, 
the α, β-double bond in conjugation with a 4-carbonyl group as well as additional 
resonance effective substituents are said to play a role in the antioxidant activity, however 
there is much contradiction around this particular aspect.   
 
R
OH
OH R R
O
O
O
.
-e , -H
+
-e , -H
+
O
-
o    semiquinone radical-  
 
Scheme 2.1: Mechanism leading to o-semiquinone radical 
 
1.1.3.2 Electrochemistry of Flavonoids 
Most Flavonoids are electroactive due to the presence of phenolic groups. The oxidation of 
flavonoids, or more importantly the ease to which flavonoids are oxidized is of great 
interest as it can be directly related to its activity as an antioxidant in the human body  
[29, 30]. Therefore electrochemical methods, such as differential pulse, cyclic and square 
wave voltammetry can be useful as a mode of detection as well as provide us with 
information regarding its reactivity as a hydrogen- or electron-donating. Using 
electrochemistry, the reducing capacity of the flavonoid substrate can be determined by 
measuring its oxidation potential and therefore providing a useful mechanism to further 
understand its structure-activity relationship.  
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1.2 Research objectives 
 
i. To determine a suitable method for the synthesis of chalcones, 
dihydrochalcones, flavanones, and prenylated flavanones. 
ii. To synthesis the above mentioned compounds with varying hydroxy, 
methoxy and prenyl group substituents. 
iii. To determine a suitable electrochemical method for the detection and 
characterization of the above mentioned compounds. 
iv. To elucidate structures of all compounds using proton and carbon nuclear 
magnetic resonance and Infrared Spectroscopy. 
v. To provide further understanding about the structure-activity relationship of 
using oxidation potentials obtained from electrochemical studies. 
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CHAPTER 2 
 
2. LITERATURE REVIEW 
 
2.1 Flavonoids in foods 
The definition of a “healthy” diet is debatable as there are beneficial and detrimental 
properties about many of the foods we eat. There is however, considerable evidence that 
suggests the high consumption of fruits and vegetables is extremely beneficial for ones 
health. Of the compounds with known structure present in fruits and vegetables, flavonoids 
deserve special attention as they are present in large amounts. Besides the flavonoids 
mentioned earlier, foods also contain flavonoid conjugates in the form of glycosides, 
flavonoid dimers, oligomers and polymers [31]. Two examples of these conjugates can be 
seen below, namely Quercetin-4-O-B-glucoside (11) and Procyanidin B1 dimer (12). 
Concentrations of flavonoids in foods do vary and are influenced by a number of factors 
such as species, variety, climate, degree of ripeness and storage.  
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(11) Quercetin - 4' - O - B - glucoside (12) Procyanidin B1 Dimer  
 
Figure 2.1: Examples of Flavonoid glucoside and Dimer [31] 
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2.1.1 Fruits 
Almost all fruits are good sources of flavonoids such as catechins, flavonols and 
proanthocyanidins. Fruits that are red or purple such as blueberries, cranberries, 
raspberries, and strawberries are said to contain high amounts of flavonoids [31]. Catechins 
are the most abundant flavonoids found in fruits, usually situated in the flesh of fruits, with 
the richest sources found in black grapes and apples. However in fruits such as apples, 
flavonols are predominantly found in the skin and therefore peeling fruits would 
significantly reduce the levels of flavonoid intake. Flavanones and flavones, a unique class 
of flavonoid, are found in citrus fruits and juices and include flavanones hesperetin, 
naringenin, quercetin and rutin [31, 32]. 
 
2.1.2 Vegetables 
As with fruits, almost all vegetables contain flavonoids although their variety is less. 
Quercetin is the key flavonoid found in garlic, leeks and onions and is best known for its 
ability to spark the immune system into action and is rapidly taking its place at the top of 
the antioxidant pyramid [32]. Onions are considered as one of the most important sources 
of the flavonoid quercetin and form a common staple in most diets around the world. 
Flavones have been found in celery, sweet peppers and lettuce.  On the other hand, 
catechins and type B procyanidins have been found in legumes. Green chilly pepper is one 
of the few vegetables to contain flavonols and flavones as well as having detectable levels 
of quercetin and luteolin respectively [32]. Soy is a good source of isoflavones. Soy 
flavonoids have been linked to greatly reduced blood cholesterol levels and the prevention 
of osteoporosis and can also play a role in managing the effects of menopause [33]. 
 
2.1.3 Beverages 
Up to 30% of white, green, and black tea leaves consist of flavonoids. However due to the 
processing of black tea and to a lesser extent green tea, the percentages are lower than in 
white tea. All members of the tea family are packed with flavonols, catechin, epicatechin, 
epigallocatechin and epicatechin gallate [34].Perhaps surprisingly; wine and more 
surprisingly beer are great sources of the flavonoids. Red grapes and the red grape skins 
which are used to make red wine contain high amounts of flavonols and flavan-3-ols such 
as  catechin, epicatechin and procyanidins [31]. It has been suggested that the low 
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occurrence of coronary heart disease in the French, despite their cholesterol-rich diet, could 
be directly linked to their relatively high intake of red wine. In recent times isoprenyl 
flavanoids namely, Xanthohumol (13), Isoxanthohumol (14) (Figure 2.2) and  
8-prenylnaringenin have been found in certain beers [35]. They occur due to the 
inflorescence (hop cones or hops) which is widely used in the brewing industry to give 
beer its characteristic fragrance, aroma, and taste. These flavonoids may be responsible for 
the antioxidant activity of lager beer, which is said to be higher than that of green tea, red 
wine, or grape juice [36]. 
 
 
O
OH
OH
OH
OMe
(13) Xanthohumol  
O
O
OH
OH
OMe
(14) Isoxanthohumol  
 
 
Figure 2.2: Structures of isoprenyl flavanoids; Xanthohumol and Isoxanthohumol 
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2.1.4 Other 
Flavonoids have also been found in many foods besides fruits and vegetables; Table 2.1 
provides more examples of these foods [37-38]. 
 
Structure Flavonoid Fruit and 
vegetables 
Beverages Other Foods 
Flavonol quercetin, onions, hot 
peppers, kale, 
broccoli, 
rutabagas and 
spinach 
Black and green 
tea 
honey 
Kaempferol cabbage, kale, 
bens, endive, 
leek, tomato, 
strawberries, 
grapes 
Teas Olive oil 
Myricetin grapes, berries, 
fruits, 
vegetables, 
herbs 
Red wine Walnuts 
Flavanol / 
Flavan-3-ol 
Catechins Legumes Oolong tea Dark chocolate 
Epicatechins Peaches All teas and red 
wines 
Chocolate, argan 
oil, vinegar 
Flavones Apigenin Celery, onions, 
lettuce, berries 
Berry juice Parsley, red 
pepper 
Luteolin beets, Brussels 
sprouts, cabbage 
and cauliflower 
 Thyme 
Tangeritin Tangerine , 
other citrus peels 
Fruit juice  
Flavanones Eriodictyol Lemons, grape Red and white peppermint 
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fruits wines 
Naringenin grapefruits, 
oranges and 
tomatoes (skin) 
Red and white 
wines 
cooked tomato 
paste 
Hesperetin Citrus fruits Red and white 
wines 
 
Prenylated 
Flavanoids 
Isoxanthohumol Hops Beer  
 
 
Table 2.1: Examples of foods containing flavonoids 
 
2.2 Flavonoids in nature 
2.2.1 Function in Plants 
Flavonoids, and their conjugates, first appearing in algae 500 million years ago, form a 
very large and remarkably diverse group of natural products. They are found in plant 
tissues, where they are present inside the cells or on the surfaces of different plant organs 
and are best known for the characteristic red, blue and purple anthocyanin pigments of 
plant tissues [39].  However their role in the beautiful display of colour is not the only 
biological function of flavonoids which is why there has been a great resurgence in 
research activity on the function of flavonoids in plants. 
 
2.2.2. Flavonoids and UV protection 
UV radiation reaching the earth’s surface is divided into lower energy UV-A (320-400 
nm), higher energy UV-B (280-320 nm) and UV-C (254-280 nm) regions [40]. The most 
severe damage caused by ultraviolet (UV) light particularly UV-B band, which causes  
most severe damage, is on the increase due to ozone reduction, which is the primary screen 
of solar radiation. Over exposure to UV-B radiation can cause cellular damage and damage 
to the chloroplast which leads to a reduction in photosynthesis [40, 41]. Flavonoids, 
situated in the epidermis of the plant, generally absorb light in the280 – 315 nm regions 
and thus act as UV filters, preventing UV-B radiation from reaching the mesophyll and 
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therefore protecting the tissue from damage and ensuring optimum plant photosynthesis 
[40]. 
 
2.2.3 Stress protection 
2.2.3.1 Temperature stress 
Flavonoids have been shown to play a role in the responses to chilling and heat stress due 
to extreme low and high temperatures. In a study of two species of hawthorn, Crataegus 
laevigata and C. monogyna, an increase in levels of colourless flavonoids (-)-epicatechin 
and hyperoside (quercetin 3-galactoside) was observed when plants were subjected to both 
cold treatment and drought stress [42]. Under these treatments it was found the antioxidant 
capacity of the shoot extracts were enhanced due to the increase in flavonoid content [42]. 
 
2.2.3.2 Heavy metal tolerance 
It is evident that flavonoids have a role in the resistance of high levels of metals in the soil.  
Aluminium toxicity in soil, said to be the most extensive problem of toxicity stress in 
plants, is a major factor constraining crop performance in tropical climates [42]. High 
levels of aluminium is said to cause oxidative stress within the plant.  However the metal 
binding activity of many flavonoids results in stable complexes with aluminium, therefore 
combating its undesirable effects [42, 43]. More evidence suggesting that flavonoids play 
an important role in metal resistance is shown by the high levels of these phenolic 
compounds that are exuded when roots of plants are exposed to aluminium. This together 
with evidence of a high stability constant for the Al complexes with pentahydroxy-flavones 
and flavan-pentols strongly supports a role for the flavonoid-type phenolics in Al 
resistance [42, 43]. 
   
2.2.3.3 Oxidative stress 
The antioxidant activity of flavonoids in humans has been well documented in the 
literature; however these biologically active compounds have been proven to serve a 
similar function in plants. Plants undergoing severe stress conditions build up dihydroxy 
B-ring-substituted ﬂavonoids, which are effective scavengers of reactive oxygen species  
(ROS) [44]. Colourless flavonoids have been found in the vacuoles and toad lesser extent 
in the cytoplasm, with the latter better sited to interact with reactive oxygen species [43]. 
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There is much evidence that flavonoid oxidation has a protective function during plant 
development and growth; for example the browning of onion scales during aging is caused 
by the oxidation of quercetin glucosides, which in turn leads to the formation of the 
antifungal agent3,4-dihydroxybenzoic acid [45]. Quinones, formed by Flavonoid oxidation 
has been shown to protect plants against pathogens as well as protecting germinating 
embryos [43]. 
 
2.3 Salutary effects in human health 
In many cultures traditional healing is sill a very popular alternative to conventional 
medicine. For centuries, preparations that contain flavonoids and there conjugates have 
been used by physicians and healers in attempts to treat disease, for example, propolis was 
prescribed by Hippocrates (460-377 BC) in Ancient Greece for the treatment of sores and 
ulcers [46]. We now understand the antimicrobial properties of propolis are attributed to its 
high flavonoid content. Other examples include the plant Tagetes miuta, containing the 
flavonoid conjugate quecetagetin-7-arabinosyl-galactoside, which was used extensively in 
Argentine traditional medicine to treat various diseases [10].   Huangchin is another 
example, used by the Chinese in which this herbal medicine has been used for the 
treatment of oral wounds. In this case the ﬂavone baicalein is reported to be largely 
responsible for this plant’s antimicrobial effects [46] 
 
2.3.1 Antioxidant activity 
2.3.1.1 Scavenging of free radicals by flavonoids 
One of the more prominent therapeutic properties of the flavonoids is their excellent 
antioxidant capacity, which is due to their radical scavenging ability. Radicals or reactive 
oxygen species (ROS) are highly reactive and are formed in vivo during normal aerobic 
metabolism, generally during oxidation reactions catalyzed by oxygenases [46, 47]. These 
reactions are very common since molecular oxygen is a very good electron acceptor. The 
transfer of electrons to dioxygen generates molecules of water, a safe product.  However 
partial reduction leads to the formation of highly toxic radicals which when produced in 
excess can cause damage to DNA, proteins, and lipids, all of which contribute to the onset 
of cardiovascular disease [46, 47]. Flavonoids possess ideal structural chemistry for the 
efficient scavenging of free radicals such as super oxide anions, singlet oxygen, nitric 
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oxide, and peroxynitrite. Flavonoids can be oxidized by radicals, resulting in more stable 
and less reactive radicals. This is due to the high reactivity of the hydroxyl group of the 
flavonoids with the reactive compound of the radicals. Therefore, flavonoids can stabilize 
the ROS and prevent oxidative injury [48].It is also a valuable aspect for therapeutic and 
prophylactic applications of flavonoids, e.g., after infection, inflammation, burns, or 
radiation injury [49]. 
 
2.3.2 Anti-inflammatory 
Inflammation is a defence system of the body to an invasion of a foreign body of any kind, 
for example bacterial cells, viruses and even wooden splinters. Inflammation involves, 
among others, the action of the complement system, blood coagulation, humeral and 
cellular immunity, cytokines, tissue hormones, angiogenesis, and repair processes [48]. 
The immune system has two branches to defend itself, the humeral and the cellular. Both 
of these branches are stimulated by flavonoids [48]. The treatment of a sore throat and 
fever with an ethanol extract of propolis is a classical example of a quick cure brought 
about by flavonoids. The pain and fever caused are a result of chemical signals from the 
point of invasion to the brain. Eicosanoids are, the compounds which release the alarm, 
and are formed from arachidonic acid by a series of enzymes. Many of these enzymes are 
inhibited by flavonoids, therefore by down-regulating them, these phenolic compounds can 
reduce thrombosis and chronic inflammatory reactions [48] 
 
2.3.3 Anti-bacterial, anti-fungal and antimicrobial activity 
Many flavonoids have been found to have excellent anti-bacterial, anti-fungal and 
antimicrobial activity [48, 50-54]. Flavonoids have been used to kill the bacterial or fungal 
cells and to counteract the spread and the effects of the bacterial toxin. Many, but not all, 
of the bacterial strains commonly encountered by humans are killed by flavonoids; 
however the mechanism by which this is accomplished is not known yet. Metabolic 
perturbation has been suggested to play a role, fungi which often accompany bacterial 
infections, may be killed by flavonoids due to this particular mechanism [48]. 
 
The antimicrobial and antifungal activity of prenylated flavonoids from five different 
medicinal plants were evaluated against the fungi; Candida albicans and Saccaromyces 
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cerevisiae, gram negative bacteria; E. coli and Salmonella typhimurium, and gram positive 
bacteria; Staphylococcus epidermis and S. aureus. All but one of the compounds tested 
showed antibacterial and/or antifungal activity with varying degrees of potency, which 
suggests that the antimicrobial activity of prenylated flavonoids is common. Furthermore 
kurarinone, a 5-methoxyflavanonecompletely inhibited the growth of all tested bacteria. 
Although further research is necessary to establish the pharmacological mechanism of the 
antimicrobial and antifungal activity it was suggested that since prenylated flavonoids are 
more hydrophobic than the conventional flavonoids, they may easily penetrate through the 
cell membrane [55]. 
 
2.3.4 Antiviral activity of Quercetin 
Quercetin has been reported to have the ability to bind to viral coat protein and 
polymerases as well as interfere with viral nucleic acid synthesis. For example, methyl 
quercetin was found to block polio virus replication by interfering with the single-stranded 
RNA. Quercetin has been further shown to have antiviral activity against enveloped 
viruses such as herpes simplex type I, respiratory syncytial, pseudorabies, parainfluenza 
type 3, and Sindbis. Quercetin has also been found to protect against macrophage-
dependent murine cardio virus (mengovirus) infection and also shown to enhance the 
antiviral activity of agents such as interferon. This ability to enhance interferon makes 
quercetin a key flavanoid for further investigation against superior viral infections such as 
HIV [56] 
 
2.3.4.1 HIV Aids 
Acquired immunodeficiency syndrome (AIDS), which is caused by the human 
immunodeficiency virus (HIV), is a devastating life-threatening pandemic. In recent times 
flavonoids have been investigated for their antiviral activity. Theoretically, flavonoids 
should have an excellent chance of preventing the proliferation of HIV since they inhibit 
reverse transcriptase, induce IFNs, and inactivate the enzyme that prepares the precursor of 
the protein building blocks of the viral capsid [48]. In an approach to discover novel 
products as new lead compounds for potential anti-HIV agents, flavonoids derived from 
organic extracts of four Desmos Lour. Species were screened against HIV-1 in infected H9 
lymphocytic cells. Three flavanones were found to exhibit antiviral activity, which 
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suggests that the flavanone C2–C3 double bond may not be necessary for antiviral activity. 
The most potent compound was found to be a chalcone [57]. The toxicity of flavonoids is 
much lower than that of current HIV drugs. The flavonoid quercetin glucuronide extracted 
from the leaves of N. nucifera, was found to have moderate anti-HIV activity and low 
cytotoxicity, which suggested that the glycosyl moiety bound to the C-3 hydroxyl group 
might also play an important role in the anti-HIV activity [58]. 
 
2.3.5 Anticancer Activity of Flavonoids 
Cancer, known medically as malignant neoplasm, embraces a group of diseases that are all 
caused by an unregulated disturbance in growth metabolism. Cancerous diseases, after 
cardiovascular disorders and accidents, kill more people before their normal life span has 
been reached. Although cancer is curable when discovered early, radical cancer treatment 
coincides with considerable life threatening dangers and discomfort and therefore there has 
been a rising interest in developing anticancer drugs from relatively non-toxic sources that 
offer some promise of a moderate, long-term life-saving cure. Flavonoids are some of the 
most promising anticancer natural products that have been tried. Related synthetic 
substances, e.g., flavone acetic acid, have been subjected to Phase I clinical trials already, 
and they may soon become adopted into the general repertoire of treatment [48]. Most 
flavonoids have proved to inhibit proliferation in many types of cultured human cancer cell 
lines, whereas they have little or no toxicity to normal human cells [47] 
 
2.3.5.1 Apigenin as a chemopreventitive agent 
Apigenin, found in many herbal teas, is one of the most bioactive plant flavones. Various 
studies have demonstrated the anti-proliferate effects of apigenin on various cancer cell 
lines including; breast, colon, cervical, lung, prostate and skin cancer cell lines. In many 
cases the cancer cell line showed complete retardation after exposure to Apigenin. These 
laboratory studies have proven that Apigenin (15) affects several critical pathways and/ or 
targets which are associated with cancer as well as help in improving cardiovascular 
conditions to stimulate the immune system, and provide some protection against cancer 
[59]. The structure of Apigenin can be seen in Figure 2.3. 
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(15) Apigenin  
 
Figure 2.3: Structure of Apigenin 
 
2.3.5.2 Quercetin as an anticancer agent 
Several studies have investigated the anti-tumorogenic effect of quercetin in cancer 
therapy. Quercetin, in a dose-dependent study, has been shown to suppress the prostate 
(PC-3) tumour growth both in vitro and in vivo. Importantly, no side effects were observed 
when serums containing concentrations of up to 12 μ M were administrated to humans. In 
a phase I clinical study achieved by Ferry et al., quercetin was safely administered by 
intravenous bolus at a dose injection [60].  Results of the plasma levels obtained showed 
inhibition of lymphocyte tyrosine kinase activity and evidence of antitumor activity [61]. 
 
In vitro studies of quercetin has also shown a wide range of inhibitory effects, for example, 
studies carried out by Debes et al that quercetin potentially may be useful in cancer therapy 
as a thermosensitizer by increasing the cell killing effect of hyperthermia and 
chemotherapy due to its ability to suppress heat shock protein expression [62]. The 
structure of Quercetin can be seen in Figure 2.4.  
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Figure 2.4: Structure of Quercetin 
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2.4 The synthesis of flavonoids 
2.4.1 Biosynthesis 
Flavonoid biosynthesis (Scheme 2.1) has been well characterized in the petunia and snap 
dragon flowers and in the kernels of maize, and is therefore one of the most well studied 
pathways among plant secondary metabolisms [63]. The first key step in the biosynthesis 
of all flavonoids is the condensation of4-coumaroyl-CoA with three molecules of malonyl-
CoA catalysed by chalcone synthase (CHS); the chalcone is stereo specifically cyclized by 
the action of chalcone isomerase (CHI) [63]. 
 
The cyclization of 2´-hydroxychalcone is a fundamental step in the biosynthesis of all 
simple flavanoids. The reaction produces the chromane core, characteristic of many 
flavonoids, and which is responsible for the colourful appearance of many flowers and the 
bitter taste of grapefruit [64]. The flavonoid Naringenin is a precursor for almost every 
other flavonoid.  Unsaturation of the C-2/C-3 bond forms flavones, which have a more 
planar skeletal ring structure. This change is able to cause a significant change the 
recognition properties of the flavonoid. When the B-ring is transferred from C-2 to C-3 the 
corresponding isoflavonoids are formed. Flavonols are flavones with a hydroxyl group at 
C-3 and in flavan-3-ols the C-4 carbonyl group has been eliminated [65]. 
 
2.4.2 Enzymes 
The flavonoid structures are derived from central and key metabolites; phosphenol 
pyruvate and erythrose-4-4phosphate via the shikimate and phenyl propanoid pathways 
and acetyl-CoA via the acetone-malonate pathway. This initial condensation reaction is 
catalyzed by chalcone synthase (CHS), thereafter the other selected enzymes are; CHI 
(chalcone isomerase); IFS (isoflavone synthase complex); FNS (flavone synthase); F3OH 
(flavanone-3-hydroxylase); FLS (flavonol synthase); DHFR (dihydroflavonol reductase) 
and AS (anthcyanidin synthase) [66] (Scheme 2.1). 
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Scheme 2.1: Biological pathway of the major flavonoid structural classes 
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2.4.3 Retrosynthetic Strategy 
The C6-C3-C6 flavonoid skeleton can be retro synthetically assessed using two of the more 
obvious analysis. One way would be to unravel the structure into a C3-C6 cinnamic acid 
type synthon that could either be a carboxylic acid, an aldehyde or an alcohol (a). 
However, these reactions are usually not simple and an alternative strategy is often 
preferred [67]. In the second strategy the flavonoid skeleton is unravelled into a C6-C2 
acetophenone and a C1-C6 benzaldehyde unit (b). This route is used more frequently in 
literature and requires easily accessible starting materials; viz., acetophenones and 
benzaldehydes. Both retro synthetic strategies can be seen in Scheme 2.2.   
 
 
(O)
C6-C3-C6
(O)
_ +
(a) (b)
(O)
_ +
+
C6 C3-C6
C6-C2
+ C1-C6
 
 
 
Scheme 2.2: Retrosynthetic analysis of C6-C3-C6 skeleton 
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2.4.4 Chalcones and Dihydrochalcones 
Chalcones (16), found abundantly in edible plants, are well known precursors in the 
metabolic pathway as well as the chemical synthesis of flavanoids [68]. They have a 
general chemical structure of two phenyl groups connected by a three carbon α, β 
unsaturated carbonyl system [(-C=C-(CO)-], see Figure 2.5. Compounds having the 
chalcone backbone have also displayed various biological and therapeutic activities [69] 
and in some cases have shown an increased antioxidant and photo-antioxidant activity due 
to the presence of the p-coumeric acid and 2-hydroxylbenzoyl moieties (Figure 2.6) [68]. 
The saturation of the C2-C3 double bond produces the corresponding dihydrochalcone (17) 
(Figure 2.5) 
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Figure 2.5: Chalcone (16) and Dihydrochalcone (17) base structures, p-coumeric acid 
and 2’-hydroxylbenzoyl moieties of the 2’-hydroxychalcone structure. 
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The base-catalyzed aldol condensation of equimolar amounts of substituted acetophenones 
and aldehydes in the presence of alcoholic alkali has been reported to show good yields 
[70-73]. This reaction is best known as the Claisen-Schmidt condensation in which a α-
proton on the acetophenone moiety is removed by a strong base, resulting in the formation 
an enolate anion which is made relatively stable by the delocalization of electrons. Next, 
the carbonyl carbon of the benzaldehyde is nucleophilically attacked by the enolate anion. 
The alkoxide is reprotonated to form an OH group, then under the basic conditions water is 
eliminated to form the thermodynamically stable α, β-conjugated enone system viz., 
chalcone. The mechanism for the Claisen-Schmidt condensation can be seen in Scheme 
2.3.    
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Scheme 2.3: Mechanism of the Claisen-Schmidt condensation 
 
In their synthetic protocol towards hydroxychalcones, Jun et al. [74] added,  
drop wise, a solution of MOM protected acetophenone and MOM protected benzaldehyde 
in methanol, to a stirred solution of KOH in water, under argon. The reaction mixture was 
kept at 0°C for 3 hours and then at room temperature for 72 hours. The mixture was then 
poured in ice water, adjusted to pH 3-4 using 1M HCl, and then extracted with ethyl 
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acetate. To remove the protecting groups the corresponding chalcone was dissolved in 
methanol and to this 3M HCl was added drop wise. The mixture was refluxed for 10 min, 
diluted with water and extracted with ethyl acetate (Scheme 2.4). 
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Scheme 2.4: Synthetic protocol towards hydroxychalcones using the Claisen-Schmidt 
condensation 
 
2.4.5 Flavanones 
In the synthetic protocol towards monohydroxyflavanones, Kagawa et al [75] cyclized 2´-
hydroxychalcones in an acidic solution; to a solution of 2´-hydroxy-3´-methoxy-
methoxychalcone in MeOH to which  26% HCl-MeOH was added and the mixture  then 
stirred at 100 °C for 2 hours. Neutralization with a saturated NaHCO3 solution and 
extraction with ethyl acetate afforded 8-hydroxyflavanone as colourless crystals  
(Scheme 2.5). 
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Scheme 2.5: Synthetic protocol towards 8-hydroxyflavanone using acidic solution 
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Soon Sung Lim et al [76] used a very different approach in their synthetic protocol towards 
6, 4´-dihydroxyflavanone (Scheme 2.6). Their synthesis started from 2´-hydroxy-5´-
methoxymethoxyacetophenone and 4-methoxymethoxy-benzaldehyde which were added 
to a mixture of H3BO3, piperidine and SiO2 in DMF. The mixture was stirred and heated to 
120 °C under nitrogen purge for 6-12 hours. The cooled mixture was diluted with acetone, 
filtered and evaporated to afford crude 5, 4´-di (methoxy-methoxy) flavanone. Thereafter 
the MOM protecting groups were removed by treating the crude flavanone with 3M HCl 
for 3 hours.  
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+ H3BO3/ Piperidine/ SiO2 
DMF
3M HCl
O
O
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Scheme 2.6: Synthetic protocol towards 5, 4´di-hydroxyflavanone using H3BO3, 
Piperidine and SiO2 
 
R. Sheng at al [77] prepared flavanone derivatives by refluxing 2´-hydroxychalcones and 
sodium acetate in a solution of ethyl alcohol and 3 drops of water for 24 hours. On the 
other hand flavone derivatives were prepared by adding the 2´-hydroxychalcones and 
iodine to a solution of concentrated H2SO4 in DMSO and warming the mixture to 80-85 °C 
and stirring for 24 hours. These two methods can be seen in Scheme 2.7.  
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Scheme 2.7:  Synthetic protocol towards flavanones using a sodium acetate reflux and a 
synthetic protocol towards flavones using iodine and conc. H2SO4 in DMSO 
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2.4.6 Prenylated Flavanoids 
Prenylated flavanoids are a unique class of naturally occurring flavonoids, widely 
distributed throughout the plant kingdom and characterized by having a prenylated side 
chain in the flavonoid skeleton. The addition of a prenyl group as an alkyl side chain has 
been shown to increase the antioxidant activity as well as to increase the degree of 
bioactivity [78]. This comes to no surprise as the prenyl group is the isoprene   unit which 
is a significant building block in biological compounds with immense activity such as 
terpenes and monocyclic terpenoids. 
 
In recent times isoprenyl flavanoids namely, Xanthohumol (18), Isoxanthohumol (19) and 
8-prenylnaringenin (20) have been found present in certain beers [79]. They occur due to 
the inflorescence (hop cones or hops) which is widely used in the brewing industry to give 
beer its characteristic fragrance, aroma, and taste. Although the brewing value of hop 
flavanoids is not well understood, these flavanoids may be responsible for the antioxidant 
activity of lager beer, which is said to be higher than that of green tea, red wine, or grape 
juice [80]. A study by C. Gerhauser et.al showed that Xanthohumol (18), and 
Isoxanthohumol (19) (Figure 2.6) both displayed excellent cancer preventative properties, 
while 8-prenylnaringenin (20) was found to be the most potent phytoestrogen known to 
date [79].These biological activities suggest that prenylflavanoids have the potential for 
application in cancer prevention programs and in prevention or treatment of (post-) 
menopausal ‘hot flashes' and osteoporosis. 
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Figure 2.6: Structures of the ‘beer flavonoids’, Xanthohumol, Isoxanthohumol and  
8-prenylnaringenin 
 
A. C. Jain et.al synthesized prenylated flavanoids using the method of nuclear 
prenylation of naringenin (21) (Scheme 2.8); with 2-methylbut-3-en-2-ol in the presence of 
boron triflouride etherate [81]. This reaction produced three products; 8-Prenylnaringenin 
(22), 6-Prenylnaringenin (23) and finally 6, 8-di-Prenylnaringenin (24). 
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Scheme 2.8:  Synthetic protocol towards prenylated flavanoids, using method of nuclear 
prenylation of naringenin 
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2.5 Electrochemistry of Flavonoids 
2.5.1 Introduction 
Electrochemical methods have been widely used for investigating flavonoids mainly on 
oxidation mechanism, metal-chelating properties, evaluation of antioxidant capacity and 
electrochemical detection [82]. The simplicity of electrochemical methods, ease of 
miniaturization, high sensitivity and relatively low cost are making it an attractive 
alternative for flavonoid detection. Electrochemical methods such as differential pulse, 
cyclic and square wave voltammetry have been intensively utilizing for analysis of certain 
flavonoids [83-87]. 
 
2.5.2 Cyclic Voltammetry 
Cyclic voltammetry has numerous advantages over the other mentioned methods; it is 
rapid, inexpensive and sensitive enough for determination of very low concentrations of 
polyphenols. A study achieved by Hotta et al, on the scavenging activities of polyphenolic 
antioxidants using cyclic voltammetry, showed an improved correlation between the 
oxidation potential and the radical scavenging abilities by introducing an anodic peak 
potential as an additional variable [88].  
 
Medvidović-Kosanović et al, performed an electrochemical study on the properties of three 
structurally different flavonoids, catechin, quercetin and rutin [89]. All measurements were 
performed on a glassy carbon electrode and results showed formation of an o-semiquinone 
radical (a good antioxidant) during of the B-ring of a flavonoid molecule. They found that 
different antioxidant capacities can be explained by the presence of a double bond between 
C-2 and C-3, conjugated with the 4-oxo group in the ring C, as well as with the presence of 
3-OH group in ring C ring. 
 
The oxidation potential of polyphenols has been regarded as an important factor for their 
antioxidant activities therefore; it has been often used for the evaluation of the antioxidant 
activity [82, 90-93]. Cyclic voltammetry is one of the most useful methods of evaluating 
the oxidation potential [94-95]. 
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2.5.3 Square Wave Voltammetry 
Square wave voltammetry has advantages when compared to differential pulse and cyclic 
voltammetry. The analysis speed is greater and there is a lower consumption of electro 
active species which causes reduced problems with blocking of the electrode surface [89]. 
 
This particular method has also been extensively used to detect polyphenolic compounds. 
In a study performed by Vojtech et al, square wave analysis was successfully used to detect 
flavonoids: quercetin, quercitin, rutin, chrysin and diosmin in human urine [96]. 
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CHAPTER 3 
 
3. SYNTHESIS OF CHALCONES, DIHYDROCHALCONES AND 
FLAVANONES 
 
3.1 Introduction  
The synthetic strategy used for the synthesis of all compounds is represented in Scheme 
3.1. Our initial strategy was to prepare starting the materials as alkoxyprotected 
acetophenones and benzaldehydes. Hydroxyl groups are present in a number of compounds 
of biological and synthetic interest, including   chalcones and flavonoids. Therefore to 
evaluate how best to maximize yields and selectivity, the OHgroups in the selected 
acetophenones and benzldehydes were protected using three different masking groups, 
namely; tetrahydropyranyl ether (THP), methoxy methyl (MOM) and benzyl ether (Bn). 
All Acetophenone products having the 2′-OH unprotected were preferred as intermediates 
since this free OH group was required for the further cyclization of the  
2-Hydroxychalcones in their corresponding flavanones.  
 
The synthetic approach towards all chalcones and dihydrochalcones was achieved in this 
work by using the base-catalyzed Claisen-Schmidt condensation between equimolar 
amounts of substituted acetophenones and substituted aldehydes in the presence of base in 
ethanol. The mechanism for the reaction is as follows; the α-proton on the acetophenone is 
removed by a strong base, resulting in the formation an enolate anion, which is made 
relatively stable by the delocalization of the electrons in the enolate. Next, the electrophilic 
carbonyl carbon of the benzaldehyde is nucleophilically attacked by the enolate anion. The 
alkoxy anion group is then protonated to form the corresponding alcohol. Base attack at the 
proton of the carbonyl results in the illumination of water to form the, β-enone chalcone as 
the first resonance stabilized product.  
 
Ring closure of the chalcone system occurs through isomerisation and gives rise to the 
corresponding alkoxyprotected flavanone. This was achieved by reacting  
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2- Hydroxychalcone intermediates with the basic salt sodium acetate, in ethanol under 
reflux. Finally, removal of the protective groups produced the hydroxyl flavanones. 
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Scheme 3.1:  The strategy used for the synthesis of Chalcones, dihydrochalcones and 
flavanones; step 1: protection of starting materials; step 2: chalcone 
synthesis; step 3: cyclisation to form flavanones; step 4: removal of 
protecting groups  
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3.2 Results and discussion  
3.2.1 Synthesis of acetophenones 1-4 
3.2.1.1 The use of dihydropyran protection groups 
2-Hydroxy- 5-tetrahydropyranylacetophenone (1) was formed in good yield by treating 2, 
5-dihydroxyacetophenone with 3, 4-dihydro-2-H-pyran (DHP) and pyridinium p-toluene 
sulphonate (PPTS) in the solvent CH2Cl2 (DCM) at room temperature for 5 hours  
(Scheme 3.2). TLC of the reaction mixture after 4 hours revealed that all starting material 
was consumed. After chromatography of the crude product, the isolated yield of the 
preferred compound (1) was 80 % along with 10 % of the unwanted 2, 5-
ditetrahydropyranyl acetophenone (1b). The steric and mainly electronic effects produced 
due to the hydrogen bonding between the OH group at position 2 and the carbonyl group 
mitigates against the formation of the dihydropyranyl acetophenone.  
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CH3
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O
CH3
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Scheme 3.2: Protection of acetophenones using dihydropyran groups. Reagents and 
conditions: i) 3, 4-dihydro-2-H-pyran, PPTS (30mg), CH2Cl2 (DCM), R.T, 
5h.  
 
The use of dihydropyran ethers as protecting groups produced reasonable yields of 
products.  However they were found to decompose over time if not protected from 
exposure to acidic fumes and environments.  This observation was confirmed by 
comparing the 1H NMR spectra of a single compound over time. It was however found that 
their stability was maintained during the Claisen-Schmidt formation of the chalcones and 
subsequent transformation into the corresponding flavanoids. 
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3.2.1.2 The use of benzyl protection groups 
Benzyl ether protected acetophenones (2-4) were synthesized by reacting appropriate 
hydroxy acetopheones with benzyl bromide in the presence of anhydrous potassium 
carbonate (K2CO3) and solvent dimethylformamide (Scheme 3.3). The reaction mixture 
was stirred for 3 hours at 80 oC. Again we observed the formation of unwanted products 
2, 5-dibenzyloxyacetophenone (2b) and 2, 4-dibenzyloxyacetophenone (3b), produced in 
low yields, 10 % and 5 % respectively. Conversely, for the protection of  
2, 4, 6-trihydroxyacetophenone, the major product was found to be the tribenzyloxy 
acetophenone (4b) with a yield of 80 % and 2-hydroxy-4, 6-dibenzyloxyacetophenone (4) 
was the minor, yield 20 %. Optimization of the yield for (6) was not conducted at this stage 
although this should be possible with some fine tuning of the stoichiometry.  
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Scheme 3.3: Protection of acetophenones using benzyl groups. Reagents and conditions, 
ii) Benzyl bromide, K2CO3, DMF, 80 
oC, 3h. 
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3.2.2 Synthesis of benzaldehydes 5-9 
3.2.2.1 The use of dihydropyran protection groups 
Pyran ether protected benzaldehydes, 4-tetrahydropyranylbenzaldehyde (5) and 
3-tetrahydropyranylbenzaldehyde (6) were both synthesized in good yields 80 % and  
75 % respectively, by stirring the appropriate hydroxyl  benzaldehydes with3,4-dihydro-2-
H-pyranin the presence of pyridinium p-toluene sulphonate (PPTS) and solvent 
CH2Cl2(DCM) for 5 hours at room temperature (Scheme 3.4). Again the pyran protected 
benzaldehydes proved to be somewhat unstable unless rigorously purified and protected 
against any acid media.  However the stability did increase when compounds (5) and (6) 
were converted to their corresponding chalcone analogues.  
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Scheme 3.4: Protection of benzaldehydes using pyran groups.  Reagents and conditions: 
i) 3, 4-dihydro-2-H-pyran, PPTS (30mg), CH2Cl2 (DCM), R.T, 5h 
 
3.2.2.2 The use of Methoxy methoxy (MOM) protection groups 
5-methoxymethyleneoxy-benzaldehyde (7) was synthesized in low yield (40%) by treating 
5-hydroxybenzaldehyde with methoxymethyl bromide (MOM-Br) in the presence of 
sodium hydride (NaH) and solvent DCM, at room temperature for 24 hours (Scheme 3.5). 
The same reaction was repeated using other solvents viz., acetone and acetonitrile to only 
produce lower yields in both cases. The methoxy-methylene-oxy masking group   is 
attached via a typical SN2reaction.  The base used removes a proton from the hydroxyl 
group present on the hydroxyl benzaldehyde forming the corresponding phenoxide anion 
causing a nucleophilic attack on the MOM-Br with displacement of the bromine. These 
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protecting groups are usually formed using the reagent MOM-Cl in good yields.  However 
due to the highly cancerous causing nature of the latter reagent it was not used. We 
ascribed our low yields obtained due to the decomposition of the MOM-Br since upon 
opening the container, HBr fumes were noticeable and thus we concluded that the MOM-
Br reagent was not suitable for the synthesis of the desired MOM derivatives.   
 
OH
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H
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ii
 
 
 
Scheme 3.5: Protection of benzaldehydes using MOM groups. Reagents and conditions: 
ii) Methoxymethyl bromide (MOM-Br) (1.1eq), NaH, Acetone, R.T, 24h 
 
3.2.2.3 The use of Benzyl protection groups 
Benzyl ether protected benzaldehydes, 4-benzyloxybenzaldehyde (8) and  
3,4,--dibenzyloxybenzaldehyde (9) were synthesized in good yield 88 % and 72 % 
respectively by treating the appropriate hydroxy  benzaldehydes with benzyl bromide in 
the presence of anhydrous potassium carbonate (K2CO3) and solvent  DMF for 3 hours at 
80oC (Scheme 3.6). 
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Scheme 3.6: Protection of benzaldehydes using benzyl groups. Reagents and conditions: 
iii) Benzyl bromide, K2CO3, DMF, 80 
oC, 3h 
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3.2.3 Synthesis of Chalcones and Dihydrochalones 
The tetrahydropyranyl-chalcones (10) and (11) were prepared in good yields of 82 % and  
85 % respectively by the Claisen-Schmidt condensation between acetophenone (1) and 
benzaldehydes (5) and (6) respectively.  An equimolar mixture of the relevant aldehyde 
and acetophenone in ethanol (95 %) was treated with KOH at 40 °C for 24 hours. Crude 
products were purified by column chromatography and thereafter the demasking of the 
pyran protecting groups in (10) and (11)  was achieved by acidic hydrolysis in which the 
THP protecting groups were removed  to produce 2, 5, 4- trihydroxychalcone  (10C) and  
2, 5, 3-trihydroxychalcone (11C) respectively b (Scheme 3.7). 
 
Saturation of the α - β double bond was achieved using catalytic hydrogenation, whereby 
chalcone 11C was dissolved in ethyl acetate and treated with Pd/C (10% w/w) as the 
heterogeneous catalyst under hydrogen pressure for 5 hours at room temperature to 
produce the hydroxy-dihydrochalcone 11D (Scheme 3.7). 
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Scheme 3.7: Synthesis of hydroxychalcones 10C and 11C and dihydrochalcone 11D.  Reagents 
and conditions: i) KOH at 40 °C for 24 hours. ii) Acid hydrolysis at room 
temperature. iii) Catalytic   hydrogenation, Pd/C, ethyl acetate, 5 hours at room 
temperature 
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3.2.3.1 Discussion 
According to literature the Claisen Schmidt condensation is performed at room 
temperature for 12-24 hours to achieve good yields (60 – 70 %) [97-100], however through 
a process of reaction optimization, we found that increasing the reaction temperature to  
40 oC improved yields to 70 – 85 %, as well as reduced the reaction time to 3 - 4 hours.  
While pyran protected chalcones 10 and 11, were prepared were prepared in good yields of 
82 and 85 % respectively, their deprotection was achieved through acid hydrolysis and 
even higher yields of 98 % and 100% for 10C and 11C respectively. The IR spectra show 
characteristic bands for C=O at 1635 - 1659, C=C Ar at 1590 and 1470, while the vinyl 
CH=CH appeared at 1285-1290 cm-1. The 1H NMR data of hydroxychalcones 10C and 
11C are understandably similar. Two pairs of trans-coupled doublets were observed in 
regions 7.50-7.90 ppm due to H-α and H-β, this anticipated spectral result was confirmed 
when compared to the known structures referenced in Sci Finder [101]. The chemical shifts 
of the H-α protons are at higher field than those of H-β protons in both chalcones. This 
observation is due to polarization of the C=C double bond which is caused by the electron 
withdrawing carbonyl group. Thus the β-C has a lower electron density and thus exhibits a 
weaker shielding effect on the β-H which is consequently less shielded and hence has a  
δ-H at lower field strength than the α-H. The coupling constant J between H-α and H-βin 
both chalcones is in the region of between 15–16 Hz which indicates an anticipated trans 
configuration [102]. The resonance signals for the hydroxyl groups appear downfield; 
however the OH group at position 2’, in  both chalcones (10C and 11C), appear 
significantly downfield at 11.85-12.87 ppm, with respect to OH signals at positions 5’, 4 
and 3 (6.50 – 10.34 ppm) and is ascribed to hydrogen bonding with the C4 carbonyl group. 
The signals for the aromatic protons for both chalcones appear in the range of 6.50-7.50. In 
the 13C NMR spectra, the C4 for chalcones 10C and 11C appears in the region of δ189 and 
204 ppm. . The α- and β-C atoms with respect to the carbonyl group gave rise to signals in 
the range of 121 -137 and again the α-C appears at a higher field than the β-C for the same 
reasons given vide infra. This data is indicative of hydroxylated chalcones and is 
summarized in Table 2. 
 
The  1H NMR spectra for hydroxyl-dihydrochalcone 11D, show two triplets, in the range of 
3.00-3.30 ppm, assigned to the hydrogen  H-α (J = 7.2 Hz) and H-β (J = 7.2 Hz) of the 
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ethano chain between to two aryl rings. The H-β signal occurs at a higher field, 3.03 ppm, 
in comparison to the H-α triplet, 3.24 ppm, this observation is due to the deshielding 
effects of the electron withdrawing carbonyl group on the H-α causing the chemical shift to 
appear further downfield. The aromatic protons for dihydrochalcone 11D appear in the 
range of 5.50 - 7.50 ppm. In the 13C NMR spectra, C4 displays a signal downfield, in the 
region of δ 201-205.6, indicative of the carbonyl group functionality [103]. Table 2 
represents a summary of the various diagnostic signals for the chalcones discussed vide 
infra. Compound 11D is known and was confirmed by comparing its spectral analysis to 
the identified compound previously synthesized by Lim et al. [104]. 
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OH
O
OH
R1
R2
OH
O
OH
OH
(10C)  R1 = H, R2 = OH
(11C)  R1 = OH, R2 = H
(11D)
 
 
 
 
 1H 13C 
Compound H-α (ppm) H-β (ppm) OH (ppm) C-α 
(ppm) 
C- β 
(ppm) 
C=O 
(ppm) 
C-OH 
(ppm) 
10C 7.54 (d, J=15Hz) 7.90 (d, J=15Hz) 2’ = 12.61,  
5’ = 10.57,  
4 = 9.24 
121.4 145.2 190.9 2’ = 154.4 
5’ = 151.6 
3 = 157.7 
11C 7.56 (d, J=15Hz) 7.90 (d, J=15Hz) 2’ = 12.01,  
5’ = 10.27,  
3 = 9.14 
121.3 145.2 203.3 2’ = 154.4 
5’ = 151.6 
4 = 157.7 
11D 3.24 
t, J=7.2 Hz 
3.03 
t, J=7.2 Hz 
2’ = 11.93 
5’ = 9.87 
4 = 9.54 
45.3 26.97 201.4 2’ =159.00 
5’ =146.40 
4’ =153.20 
 
 
Table 3.1:  Characteristic spectroscopic data of hydroxychalcones 10C, 11C and 
dihydrochalcone 11D 
 
Chalcones 10C and 11C, and Dihydrochalcone 11D are known and were confirmed by 
spectroscopy with comparisons referenced in Sci Finder [101, 102 and 104]. 
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3.2.4 Synthesis of flavanones 
3.2.4.1 The ‘simple’ flavanone 
The simple flavanone (12F) was synthesized via the Claisen Schmidt condensation of 
commercially available  2’-hydroxy-acetophenone and benzaldehyde in base (KOH) to 
form the chalcone (12C) intermediate (yield 78%), this was then cyclized, again under 
basic conditions, using sodium acetate, to form the corresponding flavanone 12F (yield 
92.8%). Scheme 3.8 below displays the complete reaction mechanism. Compounds 12C 
and 12F are known, and the characteristic signals for both the chalcone and the 
corresponding flavanone were compared with the identified structures referenced in Sci-
Finder respectively [105, 106]. 
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Scheme 3.8: Reaction mechanism for the synthesis of the ‘simple flavanone’ (12F) 
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3.2.4.2 Hydroxyflavanones and methoxy-hydroxy flavanones  
All flavanones (13F – 18F) were prepared in good yields (89 – 95 %) via the route 
synthesis discussed previously. An equimolar mixture of the relevant aldehyde and 
acetophenone in ethanol (95 %) was treated with KOH at 40 °C for 4 hours to produce the 
chalcone intermediates (13C – 18C). Crude products were purified by column 
chromatography and confirmed by NMR spectroscopy. The structural elucidation of 
compounds 13C – 15C was achieved by comparing them with references found on Sci-
finder, the chalcone moiety can easily be identified by observing two pairs of trans-
coupled doublets in regions 7.50-7.90 ppm [107-109]. Compounds 16C – 18C were found 
to be novel as no references to them were found on Sci-Finder.  
 
The chalcone intermediate, in ethanol, was treated with sodium acetate and stirred under 
reflux for 24 hours to produce the corresponding benzyloxy flavanones (13D – 15D) and 
benzyloxy methoxy flavanones (16D – 18D). The structure of compound 13D was 
compared to 4’-Benzyloxyflavanone prepared by Cabrera et al, in their investigation into 
antitumor agents [107]. Compounds 14D - 18D were found to be novel as no references to 
them were found on Sci-finder. The procedure, although seemingly simple needed some 
fine tuning in order for the reasonable yields of above 85 % to be achieved. Demasking of 
the benzyl groups for all flavanones was achieved using catalytic hydrogenation. The 
flavanones were dissolved in ethyl acetate and treated with Pd/C as the heterogeneous 
catalyst under a hydrogen  atmosphere for 5 hours at room temperature to produce 
hydroxyl-flavanones 13F – 15F (Scheme 3.10) and hydroxyl methoxyflavanones  
16F – 18F (Scheme 3.11).  
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Chalcone (11C) was the representative precursor for synthesis of the corresponding 
hydroxyl flavanone (11F) (Scheme 3.9). 
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Scheme 3.9: Synthesis of hydroxy flavanone 11F.  Reagents and conditions: i) sodium 
acetate, under reflux for 24 hours. 
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Scheme 3.10: Synthesis of hydroxyl flavanones 13F – 15F. Reagents and conditions: i) 
KOH/EtOH at 40 °C for 4 hours. ii)  Sodium acetate, under reflux for 24 
hours. iii) Catalytic hydrogenation, Pd/C, ethyl acetate, 5 hours  
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Scheme 3.11: Synthesis of hydroxyl methoxy flavanones 13F – 15F. Reagents and 
conditions: i) KOH/EtOH at 40 °C for 4 hours. ii)  Sodium acetate, under 
reflux for 24 hours. iii) Catalytic hydrogenation, Pd/C, ethyl acetate, 5 hours 
3.2.4.3 Discussion 
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Deprotection of benzyloxy flavanones 13D – 18D by catalytic hydrogenation produced 
flavanones 13F – 18F in good yields (90 - 98 %). The 1HNMR spectra of all flavanones 
12F – 18F were all characterized by the presence of two two-proton triplets, in the range of 
2.95-3.30 ppm, assigned to the hydrogens of H-3 (J = 7.2 Hz) and H-2 (J = 7.2 Hz) which 
confirms cyclisation. The H-2 triplets occur at a higher field, 2.95-3.03 ppm, in comparison 
to the H-3 triplets, 3.17-3.34 ppm, due to the deshielding effects of the electron 
withdrawing carbonyl group causing the chemical shift ofH-3 to appear further downfield. 
The resonance signals for the hydroxyl groups appear downfield as expected.  However the 
signals for the OH groups at position 6’ appear significantly downfield, 11.85-12.87 ppm, 
with respect to the other OH signals  for OH groups at positions 4’, 5’, 3 and 4  
(6.50 – 10.34 ppm). The strong deshielding of the resonances of OH protons at position 6’ 
is due to intramolecular hydrogen bonding with the peri-carbonyl group. In the case of 
hydroxyl methoxy flavanones 16F – 18F, the resonance signals for the methoxy groups 
appear up field as expected, in the region of 3.78 - 3.90 ppm. The aromatic protons for all 
flavanones 12F – 18F appear in the range of 5.50 - 7.50 ppm. The 13C NMR spectra, all 
displayed single signals in the region of δ 201-205.6, which is indicative of a ketone 
carbonyl group. The 3- and 2-C atoms with respect to the carbonyl group in the pyran ring 
gave rise to signals in the range of 30 and 75 ppm. Again the resonance signal for the3-C 
appears at a higher field than the 2-C since the 2-C is directly attached to an Oxygen. Table 
3 represents a summary of the various diagnostic signals for the flavanones discussed vide 
infra. The above mentioned flavanones have been structurally compared with their 
respective compounds found in literature, and their 1HNMR and 13C NMR signals were 
found to be indicative of the Flavanone structure [110-112]. 
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O
OR3
R1
R2
R5
R4
R6 (12F)  R1 = R2 = R3 = R4 = R5 = R6 = H
(13F)  R1 = R2 = R3 = R4 = R6 = H, R5 = OH
(14F)  R1 = R2 = R3 = R5 = R6 = H, R4 = OH
(15F)  R1 = R3 = R5 = OH, R2 = R4 = R6 = H
(16F)  R1 = R3 = R5 = H, R2 = OH, R4 = R6 = OMe
(17F)  R1 = R3 = H, R2 = OH, R4 = R5 = R6 = OMe
(18F)  R1 = R2 = OH, R3 = H, R4 = R5 = R6 = OMe
 
Compound H- 3 H- 2 OH OMe C- 2 C- 3 C=O C-OH 
12F 3.24 
t, J=7.2 Hz 
3.03 
t, J=7.2 Hz 
2’ = 11.93 
5’ = 9.4 
- 38.79 26.97 205.61 C2’ =156.69 
C5’ =153.47 
13F 3.17 
t, J=7.2 Hz 
2.98 
t, J=7.2 Hz 
2’6’ = 12.87 
4’ = 10.34 
- 45.3 26.97 201.4 C2’ =159.00 
C5’ =126.40 
C6’ =143.20 
14F 3.17 
t, J=7.2 Hz 
2.98 
t, J=7.2 Hz 
2’6’ = 12.87 
4’ = 10.34 
- 45.3 26.97 201.4 C2’ =159.00 
C5’ =126.40 
C6’ =143.20 
15F 3.17 
t, J=7.2 Hz 
2.98 
t, J=7.2 Hz 
2’6’ = 12.87 
4’ = 10.34 
- 45.3 26.97 201.4 C2’ =159.00 
C5’ =126.40 
C6’ =143.20 
16F 3.32 
t, J=7.2 Hz 
2.96 
t, J=7.2 Hz 
2’6’ = 11.85 
4’ = 6.50 
3.81- 3.90 45.3 26.97 201.4 C2’ =159.00 
C4’ =126.40 
C6’ =143.20 
17F 3.17 
t, J=7.2 Hz 
2.98 
t, J=7.2 Hz 
2’ = 12.87 
4’ = 10.34 
3.83- 3.90 44.3 26.87 201.4 C2’ =159.00 
C4’ =155.8 
18F 3.21 
t, J=7.2 Hz 
2.99 
t, J=7.2 Hz 
2’ = 11.93 
5’ = 7.63 
3.83- 3.90 45.3 26.97 201.4 C2’ =159.00 
C5’ =155.8 
 
Table 3.2: Characteristic spectroscopic data of Flavanones (12F – 18F) 
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3.3. Synthesis of 6- and 8-Prenyl Flavanones 
The synthesis of prenylated flavanones 19F and 20F was achieved by gradually treating 
Naringenin (14F) with boron trifloride etherate and 2-hydrox-2-methylbutane in dioxin at 
room temperature for 24 hours. This reaction resulted in the formation of two products, 
which could be separated chromatographically and identified as 8-C- prenylnaringenin and 
6-C- prenylnaringenin in moderate yields of 36 % and 40 % respectively (Scheme 3.12). 
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Scheme 3.12: The synthesis of prenylated flavanones 19F and 20F, Reagents and 
conditions, i) boron trifloride etherate and 2-hydrox-2-methylbutane in 
dioxin at room temperature for 24 hours 
 
 
3.3.1 Discussion 
The flavanone skeleton of compounds 19F and 20F was easily identified using 
1H NMR spectroscopy by the characteristic sets of doublets of doublets at δH5.25 – 5.39  
(J =12.0 and 4.5 Hz) for H-2a,  at δ 2.68 – 2 .99 ( J = 17 and 4.5 Hz) for H-3e [113]. A 
third  methylene doublet of doublets is observed in the range of δ 3.08 – 3.09 (J = 17.3 and  
13.0 Hz) for H – 3a, in which the large coupling is due to geminal coupling between proton 
H – 3a and H – 3e. The prenyl groups were identified by two singlets corresponding to the 
two methyl groups, appearing up field in the range of 1.67 – 1.82 ppm, as well as a 
prominent two proton doublet in the range of 3.35 – 3.37 ppm corresponding to H-1’’.   
Singlets corresponding to H-6 for compound 19F and H-8 for compound 20F were 
observed in the range of δ 5.99 – 6.02 ppm. The 1HNMR spectra for 19F and 20F   were 
understandably quite similar.  However, according to literature they may be distinguishable 
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by comparing the δ values of the singlets for H-6and H-8, with the latter appearing slightly 
downfield in all similar cases published [113].  Based on this premise, compound 19F was 
characterized as 8-C- prenylnaringenin (singlet appeared at 5.99 ppm, H-6), and compound 
20F as 6-C- prenylnaringenin (singlet appeared at 6.02 ppm, H-8).  Downfield 
exchangeable singlets at δ 12.00 ppm and 12.39 ppm, characteristic of the chelated OH 
was observed for 19F and 20F respectively. Table 4 provides a summary of the 
comparative 1H NMR spectra for the two isomers illustrating their similarities and subtle 
differences as measured on a 200 MHz spectrometer. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 3: Synthesis 
59 
 δ H 
19 F 
O
OOH
OH
OH
8
1''
 
20F 
O
OOH
OH
OH
1''
6
 
Position 
2 5.71 dd, J=13.0, 3.1Hz 5.39 dd, J=13.0, 3.1Hz 
3 2.70 dd, J=16.3, 3.4Hz, H–3a 
2.99 dd, J=16.3, 13.0Hz, H–3e 
2.68 dd, J=16.3, 3.4Hz, H–3ª 
2.89 dd, J=16.3, 13.0Hz, H–3e 
5 – OH 12.40, s 12.00, s 
6 5.99, s - 
7 – OH 11.22, s 11.01, s 
8 - 6.02, s 
2’ 7.33, d, J=8.4Hz 7.32, d, J=8.4Hz 
3’ 6.88, d, J=8.4Hz 6.88, d, J=8.4Hz 
4’ – OH 9.67, s 9.60, s 
5’ 6.88, d, J=8.4Hz 6.88, d, J=8.4Hz 
6’ 7.33, d, J=8.4Hz 7.32, d, J=8.4Hz 
1’’ 3.35, d, J=8.0Hz, 3.36, d, J=8.0Hz, 
2’’ 5.25-5.37, m 5.20-5.39, m 
4’’ 1.815, s 1.72, s 
5’’ 1.756, s 1.67, s 
 
Table 3.3: 1H NMR Spectroscopic data of Prenylated flavanoids 19F and 20F 
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CHAPTER 4 
 
4. EXPERIMENTAL 
 
4.1 Materials 
4.1.1 Purification of solvents 
All solvents used for reactions and preparative chromatography, were distilled prior to use. 
Other reagents obtained from commercial sources were used without further purification. 
 
4.1.2 Chromatographic Separations 
Preparative column chromatography was carried out on dry-packed columns using Merck 
silica gel (particle size 0.2 - 0.5 mm) as adsorbent and Merck silica gel 60                 
(0.063- 0.2 mm) as the stationary phase. Mixtures of ethyl acetate and hexane were used as 
eluent. 
 
4.1.3 Physical and Spectroscopic Data 
All melting points were obtained on a FISCHER-JOHNS melting point apparatus and are 
uncorrected.  
Proton nuclear magnetic resonance (1H NMR) and carbon nuclear magnetic resonance (13C 
NMR) spectroscopy were used for structural determination of all ligands. 1H and 13C NMR 
spectra were recorded using a Varian Gemini 2000spectrometer and chemical shifts are 
indicated in ppm.(1H, 200MHz; 13C, 50MHz).The spectra were run at ambient temperature 
in deuterated chloroform (CDCl3) solution, with CHCl3 at  7.26 for 1H NMR spectra and 
 77.00 for 13C-NMR spectra as internal standards. Sample signals are relative to the 
resonance of residual protons on carbons in the solvent. Samples were prepared weighing 
out between 30 – 60 mg of sample and dissolved in deuterated chloroform (CDCl3). In the 
NMR spectra, assignments of signals with the same superscripts are interchangeable. 
Splitting patterns are designated as “s”, “d”, “t”, “q”, “m” and “bs”. These symbols 
indicate “singlet”, “doublet”, “triplet”, “quartet”, “multiplet” and “broad singlet”. FT-IR 
measurements were used to determine the presence of functional groups in all final stage 
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unprotected chalcones and flavanones. The ATR-IR measurements were carried out on a 
Perkin-Elmer Spectrum 100 FTIR spectrometer.  
4.1.4 Other General Procedures 
The term “residue obtained upon work-up” refers to the residue obtained when the organic 
layer was separated, dried over magnesium sulphate (MgSO4) followed by filtration and 
the removal of solvent by evaporation. 
 
4.2 Characterization  
4.2.1 Pyran protected acetophenones and benzaldehydes 
 
5-Dihydropyranyl-2-hydroxyacetophenone (1) 
 
O
O
OH
O
(1)  
 
To a solution of 2, 5-dihydroxyacetophenone (1.38g; 10 mmol) and PPTS (30mg) in 
CH2Cl2 (20ml), 3, 4-dihydro-2-H-pyran (10.5g; 124 mmol) was added. The resulting 
mixture was stirred for 6 hours at room temperature. The residue obtained upon work-up 
was chromatographed using EtOAc: hexane (1:4) as eluent to afford the product (1) as 
white thick solid (1.86g; 100% based on 0.21 g recovered starting material). 
1H NMR (200 MHz, CDCl3) δ ppm 1.90 (m, 6H, 3'-, 4'- and 5'-H), 2.61 (s, 3H, CH3CO), 
3.60 (m, 1H, 6'-Ha), 3.90 (m, 1H, 6'-He), 5.31(t, 1H, J=3.2 Hz, 2'-H), 6.91 (d, 1H, 
J=8.8Hz, 3-H), 7.24 (dd, 1H, J=8.8  and 3.0 Hz, 4-H), 7.41 (d, 1H, J=3.0 Hz, 6-H).   
13C NMR δ 18.8, 25.2, 26.6, 30.6, 61.8, 96.4, 113.4, 118.6, 118.7, 132.2, 148.9, 150.9 and 
204.0. HRMS: Calc. For C13H16O4 = 236.2637. Found: = 236.2636 
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4-Dihydropyranylbenzaldehyde (5) 
 
O
H
O
O
(5)  
 
To a solution of 4-hydroxybenzaldehyde (1.22g; 10 mmol) and PPTS (30mg) in CH2Cl2 
(20ml), 3, 4-dihydro-2-H-pyran (10.5g; 124 mmol) was added. The resulting mixture was 
stirred for 6 hours at room temperature. The residue obtained upon work-up was 
chromatographed using EtOAc: hexane (1:4) as eluent to afford the product (5) as a white 
thick solid (1.14g; 68%).  
1H NMR (200 MHz, CDCl3) δ ppm 1.75 (m, 6H, 3'-, 4'- and 5'-H), 3.65 (m, 1H, 6'-Ha), 
3.95 (m, 1H, 6'-Hb), 5.50 (t, 1H, J=3.2 Hz, 2'-H), 7.15 (d, J=8.8Hz, 2H, H-3 and H-5), 7.24 
(d, 2H, J=8.8Hz,H-2 and H-6) and 9.86 (s, 1H, ~CHO). 13C NMR δ 18.8, 25.1, 30.3, 61.9, 
96.4, 115.2, 129.4, 131.1, 161.3 and 190.7. 
HRMS: Calc. For C12H14O3 = 206.2378.Found: = 206.2377 
 
3-Dihydropyranylbenzaldehyde (6) 
 
O
O
H
O
(6)  
 
To a solution of 3-hydroxybenzaldehyde (1.22g; 10 mmol) and PPTS (30mg) in CH2Cl2 
(20ml), 3, 4-dihydro-2-H-pyran (10.5g; 124 mmol) was added. The resulting mixture was 
stirred for 6 hours at room temperature. The residue obtained upon work-up was 
chromatographed using EtOAc: hexane (1:4) as eluent to afford the product (6)  
(1.09g; yield 53%).  
1H NMR (200 MHz, CDCl3) δ ppm 1.75 (m, 6H, 3'-, 4'- and 5'-H), 3.60 (m, 1H, 6'-Ha), 
3.95 (m, 1H, 6'-Hb), 5.31(t, 1H, J=3.2 Hz, 2'-H), 7.30 (m, 1H, H-5), 7.36-7.43 (m, 3H, H-2 
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, H-4 and H-6) and 9.97 (s, 1H, ~CHO). 13C NMR δ 18.8, 25.2, 30.2, 61.8, 96.5, 112.8, 
120.4, 123.2, 130.0, 137.8, 158.6 and 192.2. 
HRMS: Calc. For C12H14O3 = 206.2378. Found: = 206.2377 
 
4.2.2 MOM protected benzaldehyde 
 
3-Methoxymethyleneoxybenzaldehyde (7) 
 
OO
O
H
(7)  
 
To a stirred mixture  of 3-hydroxybenzaldehyde (1.22g, 10mmol) and sodium hydride 
(5.61g, 7mmol) in CH2Cl2 (15ml), MOMBr (1.39g, 10.1mmol) was added drop wise. The 
mixture was stirred at room temperature overnight, diluted with water (20ml), extracted 
using CH2Cl2 , washed with saturated NH4Cl (3 Х 100ml) and evaporated to dryness. The 
residue obtained upon work-up was chromatographed using EtOAc: hexane (1:4) as eluent 
to afford 3-methoxymethylene-oxybenzaldehyde (7) as a brown solid (0.49g, yield 30%) 
1H NMR (200 MHz, CDCl3) δ ppm: 3.49 (s, 3H, OCH3), 5.23 (s, 2H, OCH2OCH3), 7.29 
(m,  1H, 4-H), 7.45 (t, 1H, J=7.2 Hz, 5-H), 7.52 (m, 2H, 2- and 6-H). 13C NMR δ: 56.2, 
94.5, 113.3, 120.9, 123.0, 130.9, 137.9, 157.1 and 192.3. 
HRMS: Calc. For C9H10O3 = 166.1739. Found: = 166.1737 
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4.2.3 Benzyl protection of acetophenones/benzaldehydes 
4.2.3.1 General procedure for  benzyl protection of acetophenones/bezaldehydes 
To a solution of either the acetophenone or benzaldehyde in DMF (30 ml), K2CO3  
(3.6 mmol equiv) and the same mmol amount of  benzyl bromide as the acetophenone or 
benzaldehyde analogue was added. The reaction mixture was stirred for 3 hours at 80 oC. 
The progress of the reaction was monitored by TLC. The reaction mixture was then poured 
into water and extracted with ethyl acetate (EtOAc), and the organic portion was washed 
with brine. The organic fraction was dried over anhydrous Na2SO4, and the solvent was 
removed in vacuo to afford a residue which was then chromatographed.  
 
2-Hydroxy-5-benzyloxyacetophenone (2) 
 
O
OH
O
(2)  
 
2-Hydroxy-5-benzyloxyacetophenone (2) was synthesized from  
2, 5-dihydroxyacetophenone (3.043g; 20 mmol),  benzyl bromide (1.9 ml; 20 mmol) 
andK2CO3 (10g) according to the general procedure used for benzyl protection. The 
residue obtained upon work-up was chromatographed using ethyl acetate/ hexane (1:4) to 
afford 2-Hydroxy-5-benzyloxyacetophenone (2) as off-white thick solid (3.94g, 16 
mmol, 81 % yield). 1H NMR (200 MHz, CDCl3) δ ppm, 2.45 (s, 3H, CH3), 5.21 (s, 2H, 
CH2), 6.72 (m, 2H, 3,4-H), 7.28 (s, 1H, 6-H), 7.44 (m, 4H, Ar), 11.77 (s, 1H, 2-OH);  13C 
NMR (200 MHz, CDCl3) δppm, 30.1 (CH3), 71.0 (CH2), 115.1  (C-6), 116.6  (C-3), 119.8  
(C-4), 122.1 (C-1), 127.0  – 129.7  (5C-Ar), 141.9  (C-1'), 153.5  (C-5), 154.1  (C-2) and  
205.6 (C=O). HRMS: Calc. For C15H14O3 = 242.2699. Found: = 242.2696 
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2-Hydroxy-4, 6-dibenzyloxyacetophenone (4) 
OH
OO
O
(4)  
2-Hydroxy-4, 6-dibenzyloxyacetophenone (4) was synthesized from  
2, 4, 6-trihydroxyacetophenone (3.36g; 20 mmol),  benzyl bromide (3.8 ml; 40 mmol) 
andK2CO3 (10g) according to the general procedure used for benzyl protection. The 
residue obtained upon work-up was chromatographed using ethyl acetate/ hexane (1:4) to 
afford 2-hydroxy-4,6-dibenzyloxyacetophenone (4) as off-white solid (2.59g, 18 mmol, 
37 % yield), 1H NMR (200 MHz, CDCl3) δ ppm, 2.56 (s, 3H, CH3), 5.10 (s, 2H, CH2), 
5.28 (s, 2H, CH2), 5.88 (s, 1H,  3-H), 6.36 (s, 1H, 5-H), 7.46  (m,  10H, 2xAr), 11.93  
(s, 1H, 2-OH);  13C NMR (200 MHz, CDCl3):δppm, 31.0 (CH3), 71.1 (CH2), 71.3 (CH2),  
93.6 (C-5), 94.7 (C-3), 102.3 (C-1), 127.0 – 130.4 (C-Ar), 141.6 (C-1'), 141.9 (C-1''), 162.5 
(C-2), 165.6 (C-6), 166.7 (C-4) and 205.6 (C=O). HRMS: Calc. For C22H20O4 = 348.3918.  
Found: = 38.3915 
 
4-Benzyloxybenzaldehyde (8) 
O
H
O
(8)  
4-Benzyloxybenzaldehyde (8) was synthesized from 4-hydroxybenzaldehyde  
(2.44g; 20 mmol), benzyl bromide (1.9 ml; 20 mmol) and K2CO3 (10g) according to the 
general procedure used for benzyl protection. The residue obtained upon work-up was 
chromatographed using ethyl acetate/ hexane (1:4) to afford  
4-benzyloxybenzaldehyde (8) as brown thick solid (3.58g, 16.8 mmol, 84.4 % yield) 
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1H NMR (200 MHz, CDCl3) δ ppm, 5.18 (s, 2H, CH2),  6.88 (d, J = 7.6 Hz, 2- and 6-H), 
7.46  (m,  5H, Ar),  7.96 (d, J = 7.6 Hz, 3- and 5-H) and 10.21 (s, 1H, CHO);  13C NMR 
(400 MHz, CDCl3) δppm, 71.32 (CH2), 115.20 (C-3, C-5),  127.0 -129.9 (C-2′, C-3′, C-4′, 
C-5′ and C-6′),  128.57 (C-1),  131.11 (C-2, C-6), 136.6 (C-1′),  165.78  
(C-5), 203.66 (C=O). HRMS: Calc. For C14H12O2 = 212.2439. Found: = 212.2437 
 
 
3,4-Dibenzyloxybenzaldehyde (9) 
O
H
O
O
(9)  
3, 4-Dibenzyloxybenzaldehyde (9) was synthesized from 3, 4-dihydroxybenzaldehyde 
(2.76g; 20 mmol),  benzyl bromide (3.8 ml; 20 mmol) and K2CO3 (10g) according to the 
general procedure used for benzyl protection. The residue obtained upon work-up was 
chromatographed using ethyl acetate/ hexane (1:4) to afford  
3,4-dibenzyloxybenzaldehyde (9) as brown thick solid (4.96g, 15.6 mmol, 77.9 % yield),  
1H NMR (200 MHz, CDCl3): δ ppm, 5.22 (s, 4H, 2xCH2, ), 7.14 (dd, 1H, J =  6.4 and 2.0 
Hz,  3-H),7.21  (d, 1H, J = 2.0 Hz,  6-H), 7.29 (d , 1H, J = 6.4  Hz,  2-H), 7.42 (m,  10H, 
Ar), 10.28 (s, 1H, CH0);  13C NMR (200 MHz, CDCl3) δppm, 71.3 (CH2), 71.4  (CH2), 
114.2 (CH2), 115.1 (CH2),  123.8  -130.1(C-2′, C-3′, C-4′, C-5′, C-6′, C-2′′, C-3′′, C-4′′, C-
5′′, C-6′′),130.2 (C-1), 136.0 (C-1′), 137.2 (C-1′′),  150.8  (C-3), 154.2 (C-4) and 200.2 
(C=O). HRMS: Calc. For C21H18O3 = 318.3658. Found: = 318.3655 
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4.2.4 Synthesis of Chalcones 
4.2.4.1 General procedure for the synthesis of Chalcones 
To a solution of the substituted acetophenone (10 mmol) in EtOH (10ml-20ml), KOH  
(40 mmol) and benzaldehyde (10-12 mmol) was added. The resulting mixture was stirred 
at 40 oC for 4-5h and the progression of the reaction was monitored by TLC. After all 
reactants were consumed, the reaction mixture was poured into water and made acidic 
using 2M HCl solution. The reaction mixture was then extracted with ethyl acetate 
(EtOAc), and the organic portion washed with brine. The organic fraction was dried over 
anhydrous Na2SO4, filtered and the solvent was removed in vacuo. The compound was 
purified by column chromatography of the residue on silica gel with petroleum ether: ethyl 
acetate (4:1) as eluent. 
 
2′-Hydroxychalcone (12C) 
 
OH
O
(12C)  
2′-Hydroxychalcone (12C) was synthesized from  2′-hydroxyacetophenone (1.36g; 10 
mmol) and  benzaldehyde (1.17g; 11 mmol) according to the general procedure for 
chalcone synthesis. The residue obtained upon work-up was chromatographed using ethyl 
acetate/ hexane (1:4) to afford 2´- hydroxychalcone (12C) as brown crystals (1.75g, 7.8 
mmol, 78 % yield) Mp =86 °C (Lit.[114] Mp = 86-88 °C). IR cm-1 :  1576 (C=O).  
1H NMR (200 MHz, CDCl3): δ ppm = 6.95(d, 1H, J=2.0 Hz, 3'-H), 7.44-7.99 (m,  8H, α-
H, Ar-H), 8.01 (d, 1H, J = 15.5 Hz, , β-H), 8.12 (d,1H, J=2.0 Hz, 6'-H), 9.45 (s, 1 H, 2'-
OH). 13C NMR (200 MHz, CDCl3): δ ppm = 118.0 (3'-H), 120.2 (C-α), 121.4, 126.8, 
126.9, 128.6, 129.0, 129.4,131.3, 135.0, 136.8 (C-Ar) 145.9 (C-β), 164.0 (C-2'), 194.1 
(C=O).  HRMS: Calc. For C15H12O2 = 236.2653. Found: = 236.2651 
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2'-Hydroxy-4, 5'–dihydropyranyl-chalcone (11) 
 
OH
O
O
O
O
O
(11)  
2'-Hydroxy-4, 5'–dihydropyranyl-chalcone (11) was synthesized from  2'- hydroxy-5-
dihydropyranyl-acetophenone (1.17g; 5 mmol) and 4-dihydropyranyl-benzaldehyde 
(1.03g; 5.5 mmol) according to the general procedure for chalcone synthesis. The residue 
obtained upon work-up was chromatographed using ethyl acetate/ hexane (1:4) to afford 
2'-Hydroxy-4, 5'–dihydropyranyl-chalcone (11) as a red thick solid (1.78g, 4.2 mmol, 
83.9 % yield) 1H NMR (200 MHz, CDCl3): δ ppm 1.40-2.16 (m, 12H, 3'', 4'', 5'', 3''', 4''', 
and 5'''-H), 3.65 (m, 2H, 6''-Ha  and 6'''-Ha ), 3.90 (m, 2H, 6''-He  and 6'''-He ), 5.34 (m, 
1H, 2''-H), 5.48 (m, 1H, 2'''-H), 6.96 (d, 1H, J=9.0 Hz, H-3'), 7.14 -7.39 (m,  5H, 4',  2-,3-
,5-  and 6-H), 7.57 (d, 1H, J=16.0 Hz, β-H), 7.59 (d, 1H, J=2.0 Hz,  6'-H), 7.88 (d, 1H, 
J=16.0 Hz, , α-H), 12.44 (s, 1H,  2′-OH). 13C NMR δ: 18.7(2C), 25.1(2C), 30.2(2C), 61.9 
(2C), 96.5 (2C), 112.2, 115.9 (2C), 117.2, 118.0, 119.3, 127.4, 129.8 (2C), 135.3, 144.7, 
149.4, 155.3, 156.1 and 192.6 (C=O). HRMS: Calc. For C25H28O6 = 424.4862.  
Found: = 424.4861 
 
2'-Hydroxy-4-benzyloxychalcone (13C) 
OH
O
O
(13C)  
2'-Hydroxy-4-benzyloxychalcone (13C) was synthesized from  2′-hydroxyacetophenone 
(1.36; 10 mmol) and 4- benzyloxybenzaldehyde (2.33g; 11 mmol) according to the general 
procedure used for chalcone synthesis. The residue obtained upon work-up was 
chromatographed using ethyl acetate/ hexane (1:4) to afford  
2'- hydroxy-4-benzyloxychalcone (13C) as a orange thick solid (2.7g, 8.2 mmol,  
81.8 % yield). 1H NMR (200 MHz, CDCl3) δ ppm: 5.15 (s,  2H, CH2), 6.62 (d, 2H, J=6.0 
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Hz, , 3-, 5-H), 6.97 (m, 1H, 3'-H ), 7.35-7.46 (m, 7H, Ar-H), 7,55 (d, 1H,J=16.0 Hz, α-H), 
7.71 (d, 2H, J=6.0 Hz,  2-,6-H ), 7.81 (d, 1H, J=16.0 Hz, β-H), 8.11  
(d, 1H, J=2.0 Hz,  6'-H ),  9.83 (s, 1H, 2′-OH). 13C NMR (200 MHz, CDCl3) δppm 
70.23(CH2), 113.19 (C-3,5), 116.40 (C-3'), 121.09 (C-α), 121.89 (C-5'), 127.12  
(C-2'',6''), 127.46 (C-1'), 127.5 - 129.0 (Aryl-Cs)  132.29 (C-β '), 136.56 (C-4'), 159.88 (C-
4), 192.22 (C=O). HRMS: Calc. For C22H18O3 = 342.3872. Found: = 342.3870 
 
2'-Hydroxy-3,4-dibenzyloxychalcone (14C) 
OH
O
O
O
(14C)  
2'-Hydroxy-3, 4-dibenzyloxychalcone (14C) was synthesized from  
2′-hydroxyacetophenone (1.36g; 10 mmol) and 4, 5- dibenzyloxybenzaldehyde  
(3.5g 11 mmol) according to the general procedure used for chalcone synthesis. The 
residue obtained upon work-up was chromatographed using ethyl acetate/ hexane (1:4) to 
afford 2'-Hydroxy-3, 4-dibenzyloxychalcone (14C) as yellowish brown solid (3.67g, 8.4 
mmol, 84.2 % yield). 1H NMR (200 MHz, CDCl3) δ ppm 5.16 (s, 4H, 2xCH2),  
6.69 (m, 2H,  2- and 5-H), 6.82 (d, 1H, J=2.0 Hz,  3'-H ), 6.94 (dd, 1H, J= 6.0 and 2.0 Hz,  
5-H ),7.19 ( m,  2H,  4′- and 5′-H), 7.33-7.48 (m, 10H, Ar-H), 7.59 (d, 1H, J=16.0 Hz, α-
H), 7.68 (d, 1H, J=2.0 Hz,  6′-H ), 7.91 (d, 1H, J=16.0 Hz, β-H) and  9.89 (s, 1H, 2′-OH). 
13C NMR (200MHz, CDCl3) δppm  71.3 (2xCH2), 114.14 (C-2,5), 116.57 (C-1'), 117.98 
(C-3'), 121.04 (C- 3´), 121.39 (C-α), 123.40 (C- 6), 127.0 - 129.0 (10Cs of 2xPh rings, 
4xAryl Cs), 141.2( C-1′ and C-1′′) , 153.9 and 154.0 ( C-3 and C-4), 154.3 (C-2'),  
189.7 (C=O). HRMS: Calc. For C29H24O4 = 436.4985. Found: = 436.4982 
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2′-Hydroxy-4′, 4, 6′–benzyloxychalcone (15C) 
OH
O
O
O
O
(15C)  
2'-Hydroxy-4', 4, 6'-tribenzyloxychalcone (15C) was synthesized from  
2′-hydroxy-4′, 6′-dibenzyloxyacetophenone (1.74g; 5 mmol) and 4-
benzyloxybenzaldehyde (1.27g; 6 mmol) according to the general procedure used for 
chalcone synthesis. The residue obtained upon work-up was chromatographed using ethyl 
acetate/ hexane (1:4) to afford 2′-hydroxy-4′, 4, 6′ - tribenzyloxychalcone (15C) as 
orange solid (2.26g, 4.2 mmol, 83.7 % yield). 1H NMR (200 MHz, CDCl3) δ ppm: 5.10 (s, 
4H, CH2), 5.19 (s, 2H, CH2), 6.06 ( d, 1H, J=2.0 Hz, 3'-H), 6.29 ( d, 1H,J=2.0 Hz. 5'-H), 
6.82 (d, 2H, J= 6.0 Hz,  3,5-H ), 7.35-7.49 (m, 15H, Ar-H), 7.56 (d, 1H, J=16.0 Hz, α-H), 
7.72 (d, 2H, J= 6.0 Hz,  2,6-H ), 7.91 (d, 1H, J=16.0 Hz, β-H),  9.79 (s, 1H, 2-OH). 13C 
NMR (200 MHz, CDCl3) δppm 71.2, 71.2, 71.2 (CH2), 92.8 (C-5´), 93.3 (C-3'), 103.4 (C-
1'),  113.1 (C-3,5), 122.1 (C- α), 127.03 (C-2,6), 127.42 (C-β), 127.5 (C-1') 127.72, 127.78 
127.80, 127.88, 127.88, 127.9, 129.2, 129.2, 129.3, 129.9, 141.2 , 141.2,  141.3 (C-Ar), 
156.6 (C-2'), 163.0 (C-6'), 169.2 (C-4'), 189.9 (C=O).  
HRMS: Calc. For C36H30O5 = 542.6204. Found: = 542.6203 
 
2′-Hydroxy-5′-benzyloxy-2, 5-dimethoxychalcone (16C) 
OH
O
O
MeO
OMe
(16C)  
2′-Hydroxy-5′-benzyloxy-2, 5-dimethoxychalcone (16C) was synthesized from  
2′-hydroxy-5′-benzyloxyacetophenone (1.21g, 5 mmol) and 2, 5-dimethoxybenzaldehyde 
(0.91g, 5.5 mmol) according to the general procedure used for chalcone synthesis. The 
residue obtained upon work-up was chromatographed using ethyl acetate/ hexane (1:5) to 
afford 2'-Hydroxy-5'-benzyloxy-2,5-methoxychalcone (16C) as yellowish orange thick 
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solid (1.64g , 4.2 mmol, 84.0 % yield). 1H NMR (200 MHz, CDCl3) δ ppm:  3.78 (s, 3H, 
OCH3), 3.81 (s, 3H, OCH3), 5.16 (s, 2H, CH2), 6.85 (m, 4H, 3′,4′,3, 4-H),7.15 ( m, 2H, 6′-
H and 6-H), 7.35-7.46 (m, 5H, Ar-H), 7.69 (d, 1H, J=16.0 Hz, α-H), 8.11 (d, 1H, J=16.0 
Hz, β-H), 9.42 (s, 1H, 2′-OH). 13C NMR (400 MHz, CDCl3) δ ppm: 55.8(OCH3), 55.8 
(OCH3),71.7 (CH2),111.2 (C-6),113.6 (C-3), 114.6 (C-4),115.8 (C-6'), 116.0 (C-1') 117.9 
(C-1), 119.2 (C-3'), 121.6 (C-4'),123.8 (C-α), 127.7, 127.7, 127.8, 129.5, 129.7 (Ar-C), 
144.4 (C-β), 148.9 (C-2), 151.3 (C-2′),153.7 (C-5), 154.0 (C-5′),155.0 (C-2′), 187.6 (C=O). 
HRMS: Calc. For C24H22O5 = 390.4285. Found: = 390.4283 
 
2′-Hydroxy-5′-benzyloxy-2, 4, 5-trimethoxychalcone (17C) 
OH
O
O
MeO
OMe
OMe
(17C)  
2'-Hydroxy-5'-benzyloxy-2, 4, 5-trimethoxychalcone (17C) was synthesized from  
2'-hydroxy-5'-benzyloxyacetophenone (1.21g, 5 mmol) and 2,4,5-trimethoxybenzaldehyde 
(0.98g, 5.5 mmol) according to the general procedure used for chalcone synthesis. The 
residue obtained upon work-up was chromatographed using ethyl acetate/ hexane (1:5) to 
afford 2'-hydroxy-5'-benzyloxy-2, 4, 5-trimethoxychalcone (17C) as yellowish orange 
oil (1.78g , 4.2 mmol, 84.4% yield). 1H NMR (200 MHz, CDCl3) δ ppm:  3.74 (s, 3H, 
OCH3), 3.76 (s, 3H, OCH3),3.81 (s, 3H, OCH3), 5.21 (s, 2H, CH2), 6.18 (s, 1H, 3-H), 6.27 
(s, 1H, 6-H),6.78 (d, 1H,J=2 Hz,  6'-H), 6.88 (d, 1H, J=6.0Hz,  3'-H), 7.15 ( d, 1H, J=2.0 
Hz, 6'-H), 7.24 ( dd, 1H, J =6.0 and 2.0 Hz, 4'-H), 7.35-7.46 (m, 5H, Ar-H), 7.69 (d, 1H, 
J=16.0 Hz, α-H), 8.11 (d, 1H, J=16.0 Hz, β-H), 9.42 (s, 1H, 2'-OH). 
13C NMR (200 MHz, CDCl3)δ ppm: 54.8 (OCH3), 54.8 (OCH3),54.3 (OCH3),71.6 (CH2), 
101.3 (C-3), 109.3 (C-1'), 112,3 (C-6), 113.2 (C-6'), 115.3 (C-3'), 118.9 (C-4'),120.1 (C-1), 
123.8 (C-α), 127.7, 127.7, 127.8, 129.5, 129.7(Ar-C), 141.4 (C-1''), 142.4 (C-5), 145.4 (C-
β), 149.9 (C-2), 150.3 (C-4), 153.9 (C-5'), 154.9 (C-2'), 197.6 (C=O) 
HRMS: Calc. For C24H22O5 = 420.4545. Found: = 420.4542 
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2'-Hydroxy-4', 6'-dibenzyloxy-2, 4, 5-trimethoxychalcone (18C) 
OH
OO
O
OMe
OMe
MeO
(18C)  
2'-Hydroxy-4',6'-dibenzyloxy-2,4,5-trimethoxychalcone (18C) was synthesized from  
2'-hydroxy-4',6'-dibenzyloxyacetophenone (1.74g, 5 mmol) and 
2,4,5-trimethoxybenzaldehyde (1.08g, 5.5 mmol) according to the general procedure used 
for chalcone synthesis. The residue obtained upon work-up was chromatographed using 
ethyl acetate/ hexane (1:5) to afford 2'-hydroxy-4',6'-dibenzyloxy-2,4,5-
trimethoxychalcone (18C) as yellowish orange solid (2.25g , 4.3 mmol, 85.0 % yield). 
1H NMR (200 MHz, CDCl3) δ ppm:  3.54 (s, 3H, OCH3),  
3.66 (s, 3H, OCH3),3.71 (s, 3H, OCH3), 5.21 (s, 2H, CH2), 5.23 (s, 2H, CH2), 5.98  
(d, 1H, J=2.0 Hz,3'-H), 6.25 (d, 1H, J=2.0 Hz,5'-H),6.45 (s, 1H,  3-H), 7.29-7.56 (m,  12H, 
2xAr-H, α-H and 6-H), 8.26 (d, 1H, J=16.0 Hz, β-H), 9.62 (s, 1H, 2'-OH). 
13C NMR (200 MHz, CDCl3) 54.2 (OCH3), 54.8 (OCH3),54.9 (OCH3),72.7, 72.7 (CH2), 
92.5 (C-5'), 95.4 (C-3'), 102.2 (C-3), 109.0 (C-1'), 112.1 (C-6), 113.5 (C-6'), 120.3 (C-1), 
122.0 (C-α), 127.7, 127.7, 127.7, 127.8, 127.9, 127.9, 129.5, 129.5, 129.6, 129.6 (Ar-C), 
141.4 (C-1''), 141.6 (C-1'''),145.8 (C-β), 147.9 (C-2), 151.9 (C-4), 151.9 (C-5), 
153.3 (C-4'), 155.0 (C-2'), 189.8 (C=O). HRMS: Calc. For C32H30O7 = 526.5764. 
Found: = 526.5761 
 
4.2.4.2 General procedure for Pyran deprotection  
The pyran, 5mmol, was dissolved in THF (25 mL) and then treated with concentrated HCl 
(3 drops) and stirred at 25o C. The reaction was monitored by TLC and after all reactants 
were consumed, the reaction mixture was poured into water (100 mL) and extracted with 
ethyl acetate (EtOAc). The organic fraction was dried over anhydrous Na2SO4, and the 
solvent was removed in vacuo. The compound was purified by column chromatography on 
silica gel with petroleum ether: ethyl acetate (4:1). 
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2', 4, 5'-trihydroxychalcone (11C) 
OH
OH
OH
O  
2', 4, 5'-trihydroxychalcone (11C) was synthesized from 2′-2'-Hydroxy-4, 5'–
dihydropyran-chalcone (1.17g; 5 mmol) and 4-Benzyloxybenzaldehyde (1.03g; 5.5 mmol) 
according to the general procedure for chalcone synthesis. The residue obtained upon 
work-up was chromatographed using ethyl acetate/ hexane (1:4) to afford  
4, 5' –Dihydropyran-chalcone as an orange crystals (1.78g, 4.2 mmol, 83.9 % yield).  
Mp 215 °C (lit.[118]218 °C); IR cm-1 : 3460 (–OH), 1698 (C=O), 1616, 1523 (aromatic). 
1H NMR (200 MHz, CDCl3) δ ppm = 6.60 (d, 2H, J=6.0 Hz, H-3 and H-5), 6.85(dd, 1H, J 
=6.0 and 2.0 Hz,   H-4'), 7.12 (d, 1H, J = 2.0 Hz,   H-3'), 7.27(d,2H, J = 6.0 Hz,   H-2 and 
H-6) , 7.32 (s, 1H, H-6), 7.69 (d, 1H, J=16.0 Hz,  α-H), 8.01 (d, 1H, J = 15.5 Hz, , β-
H),11.34 (s, 1H, 4-OH and 5'-OH), 11.89 (s, 1H, 2'-OH).  
HRMS: Calc. For C15H12O4 = 256.2534 Found: = 256.2537 
 
4.2.5 Synthesis of Flavanones   
4.2.5.1 General procedure for Flavanone synthesis 
The 2′-hydroxychalcones were dissolved in EtOAc (10-20ml). To this solution 500mg of 
sodium acetate was added and the resulting mixture was stirred under reflux for 5 hours. 
The progression of the reaction was monitored by TLC. After all reactants were consumed, 
the reaction mixture was poured into water and extracted with ethyl acetate (EtOAc). The 
organic medium  was washed with brine, dried over anhydrous Na2SO4, and the solvent 
was removed in vacuo. The resulting compound was purified by column chromatography 
on silica gel with petroleum ether: ethyl acetate (4:1) as eluent to afford the final product. 
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4', 6 –Dihydroxyflavanone (11F) 
O
OH
OH
O
(11F)  
4', 6-Dihydroxyflavanone (11F) was synthesized from 2', 4, 5'-trihydroxychalcone (11C) 
(1.0g, 3.9 mmol) according to the general procedure used for flavanone synthesis. The 
residue obtained upon work-up was chromatographed using ethyl acetate/ hexane (1:4) to 
afford 4',6-dihydroxyflavanone (11F) as yellow crystals (0.79g, 3.0 mmol, 79 % yield); 
Mp = 189 - 192 °C (Lit.[115] Mp = 191 °C); IR cm-1 :1679(C=O), 1617, 1540 (aromatic). 
1H NMR (200 MHz, CDCl3) δ ppm: 3.17 (dd, 1H, J=16.3, 13.0Hz, H–3e),  
3.39 (dd, 1H, J=16.3, 3.4Hz, H–3a), 5.55 (dd, 1H, J=13.0, 3.1Hz, H–2a),  
6.60 (d, 2H, J=6.0 Hz, H-3' and H-5'), 6.85(dd, 1H, J =6.0 and 2.0 Hz,   H-7), 7.12 (d, 1H, 
J = 2.0 Hz,   H-8), 7.27(d,2H, J = 6.0 Hz,   H-2' and H-6') , 7.32 (s, 1H, H-5),  11.34 (s, 1H, 
4'-OH), 11.39 (s, 1H, 6'-OH). 13C NMR (200 MHz, CDCl3) δ ppm: 42.0 (C-3), 79.0 (C-2), 
115.3 (C-5), 115.6 (C-8), 116.9 (C-3', 5'), 120.9 (C-6), 120.4 (C-4a), 129.4 (C-5), 132.9 
(C-7), 134.2 (C-1'), 146.7 (C-4'), 146.8 (C-5'), 156.8 (C-8a), 196.9 (C=O). 
HRMS: Calc. For C15H12O4 = 256.2534. Found: = 256.25 
 
2-phenyl-2, 3-dihydro-4H-chromen-4-one (Flavanone) (12F) 
O
O
(12F)  
2-phenyl-2, 3-dihydro-4H-chromen-4-one (12F) was synthesized from  
2′-hydroxychalcone (1.12g, 5 mmol) according to the general procedure for flavanone 
synthesis. The residue obtained upon work-up was chromatographed using ethyl acetate/ 
hexane (1:4) to afford 2-phenyl-2,3-dihydro-4H-chromen-4-one (12F) as brownish white 
crystals (1.04g, 4.6 mmol, 92.8 % yield); Mp 76 °C (lit.[116] 77–78 °C); IRcm-1 : 1715 
(C=O); 1H NMR (200 MHz, CDCl3) δ ppm: 2.99 (dd, 1H, J=16.3, 13.0Hz, H–3e), 3.14 
(dd, 1H, J=16.3, 3.4Hz, H–3a), 5.53 ( dd, 1H, J=13.0, 3.1Hz, H–2a),  
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6.67 (d, 1H, J = 6.0 Hz,   8-H),6.81 (d, 1H, J =6.0 Hz, H-5), 6.95 (t, 1H, J = 6.0 Hz,  6-H), 
7.23-7.39 (m, 5H, Aryl ring), 7.62 (t, 1H, J=6.0 Hz, H-7). 13C NMR (200 MHz, CDCl3) 
δppm: 27.0 (C-3), 45.3 (C-2), 116.7, 119.4, 120.4, 120.5, 129.0, 129.4, 130.0, 131.3, 132.5, 
135.0, 136.8 (C-Ar), 164.0 (C-8a), 194.4 (C=O).HRMS: Calc. For C15H12O2 = 224.2546. 
Found: = 224.2545 
 
4′-Benzyloxyflavanone (13D) 
O
O
O
(13D)   
4′-Benzyloxyflavanone (13D) was synthesized from 2-hydroxy-4′-benzyloxychalcone 
(1.0g, 3 mmol) according to the general procedure used for flavanone synthesis. The 
residue obtained upon work-up was chromatographed using ethyl acetate/ hexane (1:4) to 
afford 4'-benzyloxyflavanone (13D) [117] as yellow crystals (0.93g, 2.8 mmol, 93 % 
yield) 1H NMR (200 MHz, CDCl3) δ ppm: 3.18 (dd, 1H, J=16.3, 13.0Hz, H–3e),  
3.32 (dd, 1H, J=16.3, 3.4Hz, H–3a), 5.15 (s, 2H, CH2), 5.43 ( dd, 1H, J=13.0, 3.1Hz, H–
2a), 6.78 (d, 2H, J =  6.0 Hz,   3'-,5'-H), 6.88 (d, 1H, J =  6.0 Hz,   8-H),  
6.95 (t, 1H, J = 6.0 Hz , 6-H), 7.10 (d, 2H, J =  6.0 Hz,  2H, 2'-,6'-H), 7.36-7.54 (m, 7H,  
Aryl-H and H-5 and H-7). 13C NMR (200 MHz, CDCl3) δ ppm: 42.57 (C-3), 68.31 (CH2), 
78.04 (C-2), 114.2 (C-8), 115.7 (C-3',5'), 120.2 (C-6), 120.5 (C-4a), 127.3 (C-2'', C-6''), 
127.7 (C-4'), 128.3 (C-2', C-6'), 129.3 (C-3'', C5''), 129.7(C-5), 132.5 (C-7), 132.9 (C-1'), 
142.0 (C-1''), 156.8 (C-8a), 159.9 (C-4'), 196.5 (C=O) 
HRMS: Calc. For C22H18O3 = 332.3906. Found: = 332.3904 
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3′, 4′-Dibenzyloxyflavanone (14D) 
O
O
O
O
(14D)   
 
3′, 4′–dibenzyloxyflavanone (14D) was synthesized from 2'-Hydroxy-4, 5-
dibenzyloxychalcone (14C) (2.18g, 5 mmol) according to the general procedure used for 
flavanone synthesis. The residue obtained upon work-up was chromatographed using ethyl 
acetate/ hexane (1:4) to afford 3′,4′-dibenzyloxyflavanone (14D) as yellow thick solid 
(2.01g, 4.6 mmol, 92 % yield) 1H NMR (200 MHz, CDCl3) δ ppm: 3.22 (dd, 1H, J=16.3, 
13.0Hz, H–3e), 3.39 (dd, 1H, J=16.3, 3.4Hz, H–3a), 5.15 (s, 4H, 2xCH2), 5.43 ( dd, 1H, 
J=13.0, 3.1Hz, H–2a), 6.54 ( d, 1H, J=2.0 Hz,  2'-H), 6.69 (d, 1H, J = 6.0 Hz,   5'-H),  
6.90 (dd, 1H, J = 6.0 and 2.0 Hz,  6′-H), 6.95 (m, 2H, 6- and8-H), 7.32–7.55 (m, 12-H, Ar). 
13C NMR (200 MHz, CDCl3) δ ppm: 42.07 (C-3), 68.31 (CH2), 68.3 (CH2), 78.46 (C-2), 
111.78 (C-5'), 114.3 (C-8), 116.7 (C-3'), 120.2 (C-2'), 120.5 (C-4a, C-6), 127.2 (C-2'', C-
6'', C-2''', C-6'''), 127.9 (C-4'', C-4'''), 129.3 (C-5'', C5'''), 129.9(C-5), 133.8 (C-7), 134.3 (C-
1'), 141.0 (C-1'', C-1'''), 149.7 (C-4') 150.4 (C-5'), 156.9 (C-8a), 198.29 (C=O). HRMS: 
Calc. For C29H24O4 = 436.4985. Found: = 436.4984 
 
4′, 5, 7- Tribenzyloxyflavanone (15D) 
 
O
O
O
O
O
(15D)  
4′, 5, 7- Tribenzyloxyflavanone (15D) was synthesized from 2'-hydroxy- 4, 4', 6-
tribenzyloxychalcone (15C) (2.0g, 3.7 mmol) according to the general procedure used for 
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flavanone synthesis. The residue obtained upon work-up was chromatographed using ethyl 
acetate/ hexane (1:4) to afford 4′, 5, 7- tribenzyloxyflavanone (15D) as yellowish brown 
solid (1.72g, 3.2 mmol, 86 % yield) .1H NMR (200 MHz, CDCl3) δ ppm 3.18 (dd, 1H, 
J=16.3, 13.0Hz, H–3e), 3.32 (dd, 1H, J=16.3, 3.4Hz, H–3a), 5.12 (s, 4H, 2xCH2), 5.23 (s, 
2H, CH2),5.43 ( dd, 1H, J=13.0, 3.1Hz, H–2a), 6.14 (s, 2H, 6- and8-H),  
6.82 (d, 2H, J =  6.0 Hz,   3'-, 5'-H), 7.13 (d, 2H, J =  6.0 Hz,   2'-,6'-H), 7.32-7.49 (m, 15-
H, Ar). 13C NMR (200 MHz, CDCl3) δ ppm: 42.6 (C-3), 68.9 (CH2), 69.2 (CH2), 69.5 
(CH2), 70.2 (C-2), 92.1 (C-6), 92.8 (C-8),100.9 (C-4a), 114.7 (C-3',5'), 127.1, 127.2 127.2, 
127.4, 128.3, 128.38, 128.4, 129.2, 129.2, 129.3, 129.9, 130.1, 130.2, 130.2, 133.0  141.2, 
141.3,  141.3 (C-Ar), 157.2 (C-8a), 159.3 (C-4′), 162.3 (C-5), 165.3 (C-7), 197.2 (C=O). 
HRMS: Calc. For C36H30O5 = 542.6204. Found: = 542.6201 
 
6-Benzyloxy-2′, 5′-dimethoxyflavanone (16D) 
O
O
O
MeO
OMe
(16D)  
 
6-Benzyloxy-2', 5'-dimethoxyflavanone (16D) was synthesized from 2'-hydroxy-6'-
benzyloxy-2, 5-methoxychalcone (16C) (1.5g, 3.8 mmol) according to the general 
procedure used for flavanone synthesis. The residue obtained upon work-up was 
chromatographed using ethyl acetate/ hexane (1:4) to afford 6-benzyloxy-2', 5'-
dimethoxyflavanone (16D) as yellowish brown solid (1.29g, 3.3 mmol, 86 % yield). 
1H NMR (400 MHz, CDCl3)δ ppm  3.18 (dd, 1H, J=16.3, 13.0Hz, H–3e),  
3.33 (dd, 1H, J=16.3, 3.4Hz, H–3a), 3.69 (s, 3H, OCH3), 3.85 (s, 3H, OCH3), 
5.18 (s, 2H, CH2), 5.21 (.dd, J=13.0 and 3.4 Hz, H-2a), 6.40 ( m, 3H, 3', 4', 6'-H), 6.76 (dd, 
1H, J=6.0 and 2.0 Hz, H-7), 7.10 (d, 1H, J=6.0 Hz H-8), 7.29 (d, 1H, J=2.0 Hz, H-5), 7.36 
– 7.58 (m, 5H, Ar-H). 13C NMR (200 MHz, CDCl3δ ppm: 43.1 (C-3), 56.2 (CH3), 57.2 
(CH3), 70.4 (CH2), 72.3 (C-2), 112.1 (C-6'), 113.6 (C-5), 115.3 (C-8), 116.1 (C-3'), 119.7 
(C-7), 122.6 (C-4a), 127.4, 127.6, 127.8, 127.3, 141.8(C-Ar), 141.2 (C-1''), 149.1 (C-
8a),149.7 (C-2'), 152.9(C-6),153.2(C-5'),196.9 (C=O). 
HRMS: Calc. For C24H12O5 = 390.4285. Found: = 390.4283 
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6-Benzyloxy-2′, 4′, 5′-trimethoxyflavanone (17D) 
 
 
 
6-Benzyloxy-2', 4', 5'-trimethoxyflavanone (17D) was synthesized from 2'-hydroxy-6'-
benzyloxy-2, 4, 5-methoxychalcone (17C) (1.5g, 3.6 mmol) according to the general 
procedure used for flavanone synthesis. The residue obtained upon work-up was 
chromatographed using ethyl acetate/ hexane (1:4) to afford 6-benzyloxy-2', 4', 5'-
trimethoxyflavanone (17D) as yellowish-green thick solid (1.42g, 3.4 mmol, 94.6 % 
yield) 1H NMR (200 MHz, CDCl3) δppm  3.13 (dd, 1H, J=16.3, 13.0Hz, H–3e),  
3.38 (dd, 1H, J=16.3, 3.4Hz, H–3a), 3.69 (s, 3H, OCH3), 3.71 (s, 3H, OCH3),  
3.76 (s, 3H, OCH3),  5.13(s, 2H, CH2), 5.17 ( dd, 1H, J=13.0 and 3.4 Hz, H-2a)6.10 (s, 1H, 
3'-H), 6.52 (s, 1H, 6'-H),6.85 (dd, 1H, J=6.1 and 2.0 Hz, H-7),  7.10 (d, 1H, J=6.1,  8-H), 
7.30 (d, 1H, J=2.0 Hz, H-5) and7.36 – 7.58 (m, 5H, Ar-H). 13C NMR (200 MHz, CDCl3)δ 
ppm: 43.0 (C-3), 56.1 (CH3), 57.2 (CH3), 57.2 (CH3), 70.9 (CH2), 73.5 (C-2), 101.8 (C-3'), 
112.4 (C-6'), 113.3(C-5), 115.3 (C-8), 119.7 (C-7), 120.1 (C-1'), 122.6 
(C-4a), 126.6, 126.7, 126.9, 127.2, 142.7(C-Ar), 141.6 (C-1''), 142.7 (C-5'), 149.1 
(C-8a),149.7 (C-4'), 150.3 (C-2'), 153.9(C-6), 198.2 (C=O).HRMS: Calc. For C25H24O6 = 
420.4545. Found: = 420.4542 
 
5, 7- Dibenzyloxy-2′, 4′, 5′-trimethoxyflavanone (18D) 
O
OO
O
OMe
OMe
MeO
(18D)  
5, 7-dibenzyloxy-2', 4', 5'-trimethoxyflavanone (18D) was synthesized from 2'-hydroxy-5', 
7'-benzyloxy-2, 4, 5-trimethoxychalcone (18C) (1.5g, 2.8 mmol) according to the general 
O
O
O
MeO
OMe
OMe
(17D)
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procedure used for flavanone synthesis. The residue obtained upon work-up was 
chromatographed using ethyl acetate/ hexane (1:4) to afford  
5, 7-dibenzyloxy-2′, 4′, 5′-trimethoxyflavanone (18D) as yellowish-green thick solid 
(1.45g, 2.75 mmol, 96.7 % yield) 1H NMR (200 MHz, CDCl3) δppm  3.14 (dd, 1H, 
J=16.3, 13.0Hz, H–3e), 3.37 (dd, 1H, J=16.3, 3.4Hz, H–3a), 3.58 (s, 3H, OCH3), 3.61 (s, 
3H, OCH3), 3.66 (s, 3H, OCH3), 5.12 (s, 2H, CH2), 5.16 (s, 2H, CH2), 5.48 ( dd, 1H, 
J=13.0 and 3.4 Hz, H-2a ), 6.13 (s, 1H, H-3'), 6.22 (s, 1H,  H-6'), 6.35 ( d, 1H, J=2.0 Hz, 
H-8) , 6.39 ( d, 1H,J=2.0 Hz.H-7), , 7.26 – 7.52 (m, 10H, Ar-H). 13C NMR (200 MHz, 
CDCl3)δ ppm: 42.4 (C-3), 57.0 (CH3), 57.2 (CH3), 57.2 (CH3), 69.9(CH2), 67.1 (CH2), 
73.2 (C-2), 91.8 (C-6), 92.8 (C-8), 101.3 (C-4a), 102.1 (C-3'), 113.4 (C-6'), 121.7 (C-1'), 
126.6, 126.7, 126.9, 126.9, 128.6, 128.7, 128.7, 129.0, 142.7,  142.8 (C-Ar), 142.9 (C-5'), 
148.9 (C-4'), 151.3(C-2'), 159.2 (C-8a), 161.9(C-5), 197.2 (C=O). HRMS: Calc. For 
C32H30O7 = 526.5764. Found: = 526.5762 
 
4.2.5.2 General procedure for Debenzylation. 
Cleavage of the benzyl ethers was performed by catalytic hydrogenation over Pd/C. The 
protected chalcone/flavanoid (1 gm) was dissolved in ethyl acetate (10ml) and to this 10% 
Pd/C  (20 mg) was added. The apparatus was opened and ﬂushed with hydrogen. Two 
vacuum/H2 cycles to replace the air inside with hydrogen was completed. The mixture was 
vigorously stirred at room temperature under hydrogen pressure for 24 h. The progression 
of the reaction was monitored by TLC and when all reactants were consumed the reaction 
mixture was filtered using a membrane filter (Millipore, Millex_-LH, 0.45 mm) and the 
filtrate was concentrated to provide the crude product. 
 
4′-Hydroxyflavanone (13F) 
 
O
O
OH
(13F)  
4'-Hydroxyflavanone (13F) was synthesized from 4´-benzyloxyflavanone (13D)  
(1.0g, 3mmol) according to the general procedure used for benzyl de-protection. The 
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residue obtained upon work-up was chromatographed using ethyl acetate/ hexane (1:4) to 
afford 4′-hydroxyflavanone (13F) [119]as yellowish white crystals(0.69g, 2.9 mmol, 95.8 
% yield). Mp 190 °C (lit.[119] 192-193 °C). IR cm-1 : 3459 (–OH), 1699 (C=O), 1H NMR 
(200 MHz, CDCl3) δ ppm: 3.18 (dd, 1H, J=16.3, 13.0Hz, H–3e),  
3.32 (dd, 1H, J=16.3, 3.4Hz, H–3a), 5.53 ( dd, 1H, J=13.0, 3.1Hz, H–2a),  
6.68 (d, 2H, J = 6.0 Hz,  H-3'and H-5'),  6.85 (d, 1H, J = 6.0 Hz,  H-8), 6.95 (t, 1H, J = 6.2 
Hz,  H-6), 7.10 (d, 2H, J = 6.2 Hz,  H-2' and H-6'), 7.41-7.54 (m, 2H, H-5 and H-7).  
13C NMR (200 MHz, CDCl3) δ ppm: 42.55 (C-3), 78.94 (C-2), 115.3 (C-8), 115.72  
(C-3',5'), 120.38 (C-6), 120.54 (C-4a),  128.35 (C-2', C-6'), 129.76 (C-5), 132.5 (C-1'), 
132.91 (C-7), 156.74 (C-8a), 157.76 (C-4'), 196.89 (C=O). HRMS: Calc. For C15H12O3 = 
240.2540. Found: = 240.2543 
 
 
3', 4’ -Dihydroxyflavanone (14F) 
O
O
OH
OH
(14F)  
3', 4’- dihydroxyflavanone (14F) was synthesized from 3', 4’-di-benzyloxyflavanone (14D) 
(1.5g, 3. 4 mmol) according to the general procedure used for benzyl de-protection. The 
residue obtained upon work-up was chromatographed using ethyl acetate/ hexane (1:4) to 
afford 3', 4’-dihydroxyflavanone (14F) as yellowish-brown crystals (0.80g, 3.1 mmol, 
90.9 % yield).Mp 177 °C (lit. [120] 175 - 177 °C). IR cm-1 : 3347 (–OH), 1712 (C=O), 
1589, 1549 (aromatic). 1H NMR (200 MHz, CDCl3) δ ppm 3.15 (dd, 1H, J=16.3, 13.0Hz, 
H–3e), 3.41 (dd, 1H, J=16.3, 3.4Hz, H–3a), 5.59 ( dd, 1H, J=13.0, 3.1Hz, H–2a),  
6.44 (d, 1H, J=2.0Hz, H-2'),  6.49 (d, 1H,J =  6.0 Hz,  H-4'), 6.58 (dd, 1H, J = 6.0 and 2.0 
Hz,  H-6'), 6.85 (d, 1H, J = 7.0 Hz,  H-8), 6.98 (t, 1H, J = 7.0 H-6), 7.47 (d, 1H, J = 7.0 Hz,   
5-H),  (t, 1H, J = 7.0Hz, H-7), 11.34 (s, 1H, OH), 11.39 (s, 1H, OH).13C NMR (200 MHz, 
CDCl3) δ ppm: 42.8 (C-3), 79.1 (C-2), 114.2 (C-2' and C-6'), 115.7 (C-8), 120.4 (C-6), 
120.4 (C-4a), 127.8 (C-3'), 129.4 (C-5), 132.9 (C-7), 134.2 (C-1'),  
146.7 (C-4'), 146.8 (C-5'), 156.8 (C-8a), 196.9 (C=O) 
HRMS: Calc. For C15H12O4 = 256.2534. Found: = 256.2530 
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4', 5, 7 Trihydroxyflavanone (15F) 
O
O
OH
OH
OH
(15F)  
4', 5, 7 Trihydroxyflavanone (15F) was synthesized from 4', 5, 7-tribenzyloxyflavanone 
(1.5 g, 2.8 mmol) according to the general procedure used for benzyl de-protection. The 
residue obtained upon work-up was chromatographed using ethyl acetate/ hexane (1:4) to 
afford 4', 5, 7-trihydroxyflavanone (15F) as yellow crystals (0.69g, 2.5 mmol, 92 % 
yield). Mp 247 °C (lit. [121] 247 - 249 °C). IR cm-1 : 3446 (–OH), 1698 (C=O), 1616, 
1540 (aromatic), 1H NMR (200 MHz, CDCl3) δ ppm 3.13 (dd, 1H, J=16.3, 13.0Hz, H–3e),  
3.29 (dd, 1H, J=16.3, 3.4Hz, H–3a), 5.42 ( dd, 1H, J=13.0, 3.1Hz, H–2a), 5.76 (s,1H, 6-H), 
5.89 (s,1H, H-8)6.72 (d, 2H, J = 6.3  Hz, H-3' and H-5'), 7.13 (d, 2H, J = 6.3  Hz, H-2'- and 
H-6'), 9.79 (s, 1H,  4'-OH),11.34 (s, 1H,  7-OH) and  11.39 (s, 1H,  5-OH). 13C NMR (200 
MHz, CDCl3) δppm 43.7 (C-3), 70.2 (C-2), 94.1 (C-8), 95.3 (C-6), 101.9 (C-4a),116.0 (C-
3',5'), 128.1 (C-2',6'), 132.9 (C-1'), 157.2 (C-4'), 159.3 (C-8a), 162.8 
(C-5), 164.2 (C-7), 196.8 (C=O).HRMS: Calc. For C15H12O5 = 272.2528.  
Found: = 272.2525 
 
6-Hydroxy-2′, 5′-dimethoxyflavanone (16F) 
O
O
OH
MeO
OMe
(16F)  
6-Hydroxy-2', 5'-dimethoxyflavanone (16F) was synthesized from  
6-benzyloxy-2', 5'-dimethoxyflavanone (1.0g, 2.56 mmol) according to the general 
procedure used for benzyl de-protection. The residue obtained upon work-up was 
chromatographed using ethyl acetate/ hexane (1:4) to afford  
6-hydroxy-2', 5'-dimethoxyflavanone (16F) as red-brown thick solid (0.72g, 2.4 mmol,  
94 % yield). 1H NMR (400 MHz, CDCl3) δ ppm 2.88 (dd, 1H, J=16.3, 3.4Hz, H–3a), 3.00 
(dd, 1H, J=16.3, 13.0Hz, H–3e), 3.80 (s, 3H, OCH3), 3.84 (s, 3H, OCH3), 5.78 (dd, 1H, 
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J=13.0, 3.1Hz, H–2a), 6.72 (s, 1H, 6-OH), 6.87 (m, 2H, H-3' and H-4'), 6.98 (d, 1H, J=6.8 
Hz, H-8), 7.12 (dd, 1H,J=6.8, 2.0 Hz, H-7), 7.24(s, 1H, H-2'), 7.42 (d, 1H, J=2.0  Hz, H-5). 
13C NMR (400 MHz, CDCl3) δppm 43.7 (C-3), 55.8 (2′-OCH3), 56.0 (5'-OCH3), 74.7 (C-
2), 111.1 (C-5), 111.6 (C-3'), 112.6 (C-4'), 113.7 (C-8), 119.5 (C-4a), 124.9 (C-7), 128.6 
(C-1'), 149.9 (C-5'), 150.1 (C-6'), 150.4 (C-2'), 153.8 (C-6), 156.4 (C-8a), 193.4 (C=O). 
HRMS: Calc. For C17H16O5 = 300.3059. Found: = 300.3056 
 
6-Hydroxy-2', 4', 5'-trimethoxyflavanone (17F) 
O
O
OH
MeO
OMe
OMe
(17F)  
6-Hydroxy-2', 4', 5'-trimethoxyflavanone (17F) was synthesized from  
6-benzyloxy-2', 4', 5'-trimethoxyflavanone (1.0g, 2.4 mmol) according to the general 
procedure used for benzyl de-protection. The residue obtained upon work-up was 
chromatographed using ethyl acetate/ hexane (1:4) to afford  
6-hydroxy-2', 4', 5'-trimethoxyflavanone (17F) as yellow crystals (0.70g, 2.1 mmol,  
89.1 % yield).Mp 175 °C (lit. [122] 175 - 177 °C). IR cm-1 : 3458 (–OH), 1698 (C=O), 
1616, 1540 (aromatic). 1H NMR (400 MHz, CDCl3) δ ppm:3.00 (dd, 1H, J=16.3, 13.0Hz, 
H–3e), 3.23 (dd, 1H, J=16.3, 3.4Hz, H–3a),3.84 (s, 3H, OCH3), 3.86 (s, 3H, OCH3), 3.90 
(s, 3H, OCH3), 5.70 (dd, 1H, J=13.0 and 3.4 Hz, H-2a), 6.54 (s, 1H, H-3'), 6.77 ( s, 1H, H-
6') , 6.88 (d, 1H, J=6.0Hz, H-8), 7.26 (dd, 1H, J=6.0 and  2.0 Hz, H-7), 7.06 (d, 1H,J=2.0 
Hz.H-5) 7.63 (s, 1H,  6-OH). 13C NMR (200 MHz, CDCl3) δppm 26.97 (C-3), 45.3 (C-2 ), 
56.5 (OCH3), 57.3 (OCH3), 58.1 (OCH3), 100.2 (C-3'), 112.5 (C-7, C-6'), 118.2 (C-1'), 
119.5 (C-'), 122.3 (C-8), 126.4 (C-4'), 143.2 (C-5), 150.9 (C-4'), 151.8 (C-6), 155.8 (C-5'), 
159.0 (C-2'), 201.4 (C=O). HRMS: Calc. For C18H18O6 = 330.3319. Found: = 330.3317 
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5, 7-Dihydroxy-2', 4', 5'-trimethoxyflavanone (18F) 
 
O
O
MeO
OH
OH
OMe
OMe
(18F)  
5, 7-Dihydroxy-2', 4', 5'-trimethoxyflavanone (18F) was synthesized from 5, 7-
dibenzyloxy-2′, 4′, 5′-dimethoxyflavonone (1.0g, 1.9 mmol) according to the general 
procedure used for benzyl de-protection. The residue obtained upon work-up was 
chromatographed using ethyl acetate/ hexane (1:4) to afford 5, 7-dihydroxy-2', 4', 5'-
trimethoxyflavanone (18F) as reddish-brown thick solid (0.62g, 1.79 mmol, 94 % yield). 
IR cm-1 : 3468 (–OH), 1668 (C=O). 1H NMR (400 MHz, CDCl3) δ ppm 2.83 (dd, 1H, 
J=16.3, 13.0Hz, H–3e), 3.00 (dd, 1H, J=16.3, 3.4Hz, H–3a), 3.84 (s, 3H, OCH3), 3.90 (s, 
3H, OCH3), 3.94 (s, 3H, OCH3), 5.76 (dd, 1H, J=13.0, 3.1Hz, H–2a), 6.03 (s, 2H, H-6 and 
H-8), 6.57 (s, 1H, H-3'), 7.10 (s, 1H, H-6'), 9.43 (s, 1H, 7-OH), 12.15 (s, 1H, 5-OH).  
13C NMR (400 MHz, CDCl3) δppm: 42.4 (C-3), 55.9 (OCH3), 56.09 (OCH3), 56.4 
(OCH3), 75.4 (C-2), 95.9 (C-8), 96.9 (C-6), 102.6 (C-3'), 103.1 (C-4a), 118.8 (C-6'), 119.6 
(C-1'), 144.2 (C-5'), 151.0 (C-4'), 151.8 (C-2'), 165.5 (C-5), 165.8 (C-8a) 167.7 (C-7) 197.8 
(C=O). HRMS: Calc. For C18H18O7 = 346.3313. Found: = 346.3312 
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4.2.6 Synthesis of Prenylflavanones 
 
8-C-Prenylnaringenin (19F)                           6-C Prenylnaringenin (20F) 
O
O
OH
OH
OH
CH3CH3
(19F)    
O
O
OH
OH
OH
CH3
CH3
(20F)  
To a stirred solution of naringenin (1.1g, 4mmol) in dioxan (8ml) was added gradually 
BF3-etherate (0.6ml, 4.8mmol) at room temperature. To this solution, 2-methyl-but-3-en-2-
ol (0.8ml, 7.6mmol) was added and the resulting solution was stirred at room temperature 
overnight. The residue obtained upon work-up was chromatographed using EtOAc: hexane 
(1:3) as eluent to afford three fractions.  
Fraction A:  yellow thick solid (0.38g, 28 % yield) and was characterized as 
8-C-prenylnaringenin. 1H NMR (200 MHz, CDCl3): 1.76 , 1.82  (2xs, 3H each , Me2C=), 
2.77 (dd, 1H, J=16.0 and 4.0Hz, , H-3a), 3.08 (dd, 1H, J=16.0  and 12.0Hz,  H-3e ) ,  
3.35 (d, 2H, J=8.0Hz,  H-1''), 5.25-5.37 (m, 2H, H-2 and H-2''), 5.99 (s, 1H, H-6),  
6.88 (d, 2H, J=8.4Hz,  H-3' and H-5'), 7.33 (d, 2H, J=8.4Hz,  H-2' and H-6') and  
12.40  (s, 1H, chelated 5-OH). HRMS: Calc. For C20H20O5 = 340.3698.  
Found: = 340.36.95 
Fraction B: yellow thick solid (0.44g, 32 % yield) and was characterized as  
6-C-prenylnaringenin. 1H NMR (200 MHz, CDCl3): 1.67, 1.72 (2xs, 3H each , Me2C=), 
2.89 (m, 2H, H-3a and H-3e) , 3.35 (d, 2H, J=8.0Hz,  H-1''), 5.20-5.39 (m, 2H, H-2 and H-
2''), 6.02 (s, 1H, H-8), 6.88 (d, 2H, J=8.4Hz,  H-3' and H-5'), 7.32 (d, 2H, J=8.4Hz,  H-2' 
and H-6') and 12.00 (s, 1H, chelated OH).HRMS: Calc. For C20H20O5 = 340.3698, Found: 
= 340.36.95 
Fraction C upon crystallization afforded the starting material, Naringenin  
(0.51g, 37 % yield)  
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4.3 Electrochemistry 
4.3.1 Preparation of solutions 
Phosphate buffer solution was prepared by mixing appropriate volumes of 0.1Msodium 
dihydrogen phosphate (NaH2PO4) and 0.1M sodium hydrogen phosphate (Na2HPO4) with 
ultra-pure water with a conductivity of 5.5 X 10-6 S.m-1 to produce the desired pH. 
Ethanol was selected as the most suitable solvent, all chalcones and Flavanones were 
dissolved in absolute ethanol to produce various concentration ranges between 0.049 and 
0.22 M. 
 
4.3.2 Voltammetric measurements 
For electrochemical measurements, a three electrode cell consisting of a 3 mm diameter 
glassy carbon working electrode, a platinum wire auxiliary electrode, and an Ag/AgCl  
(3 M NaCl) reference electrode were used. The surface of the glassy carbon electrode was 
freshly polished with 1.0 um, 0.05 μm and 0.3 μm alumina powder on a micro cloth pad, 
rinsed with distilled water and degreased with ethanol in an ultrasonic bath because of 
possible film formation and memory effects [123]. The GCE was also electrochemically 
cleaned with 1M H2SO4 and rinsed with distilled water. After electrochemical cleaning of 
the GCE, the required volume of sample was added by micro pipette into supporting 
electrolyte. The potentials were recorded against the silver-silver chloride electrode as a 
reference electrode used in conjunction with the platinum electrode placed in a 50 ml 
volume glass cell together with the glassy carbon electrode. Phosphate buffer (5ml) of pH 
~ 7 was used as the supporting electrolyte. The scan was taken in a potential range of – 
1500 mV and + 1500 mV with the following scan rates 20, 50 and 100 mV/s for cyclic 
voltammetric measurement and the scan was taken in the same potential window with a 
frequency of 15 hertz for square wave measurements. Prior to each measurement, the 
background currents were measured in phosphate buffer alone and subtracted from the 
currents measured with compound added in phosphate buffer. In order to minimize 
adsorption onto the electrode surface, measurements were performed immediately after the 
addition of the compound. The sample in the electrochemical cell was de-aerated by 
purging with high purity argon during electrochemical measurements. All experiments 
were carried out at room temperature. For square wave measurements, determination of the 
flavonoids was carried out at a frequency of 15 Hz, step potential 20 mV/s with phosphate 
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buffer of pH 7 as supporting electrolyte. For smoothing and baseline correction the 
software Origin 7 was employed. 
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CHAPTER 5 
 
5. ELECTROCHEMISTRY 
 
5.1 Introduction 
Cyclic Voltammetry and square wave voltammetry were used to investigate flavonoid 
characteristics by the peak potential, number and position of peaks at those potentials, the 
current heights at each peak potential for all flavanoids. Square wave voltammetry, as 
expected, proved to more sensitive and therefore the peak potentials in its voltammograms 
were used to determine the oxidation peak potentials. According to literature, the first 
anodic peak will provide us with the most useful information about the compound’s 
antioxidant activity, it is suggested that the lower the oxidation potential of the first anodic 
peak the greater the ability of a compound to donate an electron and hence behave as an 
antioxidant [124, 125]. This was rationalized on the basis that both electrochemical 
oxidation and hydrogen donating free radical-scavenging involve the breaking of the same 
phenolic bonds between oxygen and hydrogen, producing the phenoxyl radical and H', 
which consists of an electron and an H ÷ ion [126]. This will be the main focus, and the 
antioxidant activity of all flavanoids was determined by comparing the oxidation potential 
of this first anodic peak.   
 
The antioxidant activity of flavonoids and their metabolites in vitro depends upon the 
arrangement of functional groups about the nuclear structure. In this study we have 
investigated a number of structural variants namely: a) the number and position of 
hydroxyl groups attached to the flavanoid backbone; b) the importance of the α, β double 
bond functionality; c) the effect of ring closure; d) the effects of methoxy groups 
introduced to the flavanoid backbone; and finally e) the effect of prenyl groups introduced 
to the flavanoid backbone. 
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Compound 12F:   Flavanone (2-phenyl-2, 3-dihydro-4H-chromen-4-one) 
 
 
Figure 5.1: Cyclic voltammogram of compound 12F, scan rate 100 mV/s. 
 
 
 
Figure 5.2: Square wave voltammogram of compound 12F, scan rate 20 mV/s. 
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Figure 5.1 shows the cyclic voltammogram of compound 12F, recorded when the potential 
sweep was started from -1500 mV to +1500 mV and reversed at a scan rate of 100mV/s. 
The corresponding reduction peak points to reversibility. The square wave voltammogram 
of compound 12F (Figure 5.2) shows two sets of peaks; one at 24.4 mV and the other at 
776 mV. The first peak at 24.4 mV was observed in the blank run (without addition of 
sample) as well and was consequently ignored. This initial peak was consistently observed 
throughout the study, and its peak potential was ignored unless there was clear evidence of 
oxidation occurring in that specific potential range. The second peak, as shown, is not that 
clearly defined.   However it was validated by performing a number of scans using the 
specific concentration of 100 µM to observe its repeatability.  
 
 
Compound 13F: 4’-Hydroxyflavanone 
 
 
 
Figure 5.3: Cyclic voltammogram of compound 13F, scan rate 100 mV/s. 
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Figure 5.4: Square wave voltammogram of compound 13F, scan rate 20 mV/s. 
 
 
Figure 5.3 shows the cyclic votammogram of 4’-Hydroxyflavanone, recorded when the 
potential sweep began from 1500 mV to + 1500 mV. A distinct peak at 780 mV was 
observed. The square wave voltammograms between 12F and 13F showed a very close 
similarity and consequently it would appear that the addition of a hydroxyl group at 
position 4’ has had little or no effect to the oxidation potential of the favanoidal system.   
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Compound 14F:  3’, 4’-dihdroxyflavanone 
 
 
Figure 5.5: Cyclic voltammogram of compound 14F, scan rate 100 mV/s. 
 
 
 
 
Figure 5.6: Square wave voltammogram of compound 14F, scan rate 20 mV/s. 
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The cyclic voltammogram (Figure 5.5) shows oxidation of the ortho-dihydroxy-phenol 
groups which results in the formation of a semi-stabile ortho-quinone, which becomes 
reduced in the reversed scan, appearing as a cathodic peak. The square wave 
voltammogram of compound 14F (Figure 5.6) shows a defined peak at 596 mV, and a 
secondary peak at 1108 mV, which indicates secondary oxidation. 
 
5.2 Comparative Assessment 
The B-ring hydroxyl configuration does appear to be a significant factor determining the 
radical scavenging ability of flavonoids. Hydroxyl groups on the B-ring in general are able 
to donate an electron to form either hydroxyl, peroxyl or peroxy nitrite radicals, and 
stabilizing them, giving rise to a relatively stable flavonoid radical system [127]. By 
comparing the square wave voltammograms of compounds 12F, 13F and 14F one is able 
to obtain a greater understanding of the structure-reactivity relationship, namely, what 
effect the addition of hydroxyl groups on the B-ring has on the oxidation potential.  
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Figure 5.7: Superimposition of the square wave voltammograms of compounds 12F, 13F 
and 14F 
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By comparing the oxidation potential of compound 12F (776 mV) and compound 13F 
(780 mV) it is clear that the addition of a hydroxyl group at position 4’ on the B-ring had 
very little effect on the oxidation potential.  As the oxidation potential is directly related to 
antioxidant activity we can assume that the two compounds would perform fairly similarly 
in vitro. In compound 14F on the other hand, with an additional hydroxyl group at position 
5’ compared to 13F, a much lower oxidation potential (596 mV) for the first anodic peak 
was observed, which again according to literature, would correspond with a higher 
antioxidant activity [124, 125]. This result was expected as it has been suggested in the 
literature that the higher the number of hydroxyl groups on the B ring, the more enhanced 
the flavonoid activity would be [128]. The square wave voltammogram of Compound 14F 
also shows a secondary anodic peak at the potential 1108 mV. It is known that oxidation of 
phenolic groups occur at moderate too high positive potentials forming a phenoxy radical 
or a phenoxonium ion that can successively undergo different secondary reactions [129]. 
The secondary peaks can be attributed to secondary oxidations occurring within the 
compound. 
 
 
In terms of increasing antioxidant activity, the compounds may thus be arranged as 
follows:  
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Compound 11D: 2, 5, 4’-trihydroxy dihydrochalcone 
 
 
Figure 5.8: Cyclic voltammogram of compound 11D, scan rate 100 mV/s. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.9: Square wave voltammogram of compound 11D, scan rate 20 mV/s. 
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Figure 5.8 shows the cyclic voltammogram of compound 11D, recorded when the 
potential sweep was begun from -1500 mV to +1500 mV and reversed at a scan rate of 100 
mV/s. The square wave voltammogram of compound 11D (Figure 5.9) shows a very timid 
peak at 680 mV. Again multiple scans where conducted to test the validity of this peak. 
 
 
Compound 11C: 2, 5, 4’-trihydroxychalcone 
 
 
 
 
Figure 5.10: Cyclic voltammogram of compound 11C, scan rate 100 mV/s. 
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Figure 5.11: Square wave voltammogram of compound 11C, scan rate 20 mV/s. 
 
 
The square wave voltammogram of compound 11C (Figure 5.10) shows three sets of 
defined peaks;  one at -1124 mV, the second at 672 mV and the third at 1248 mV. 
Interestingly the first anodic peak marked as 1 in the voltammogram occurs at a very low 
oxidation potential which suggests high antioxidant activity [125]. 
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Compound 11F: 4’, 6-Dihydroxyflavanone  
 
Figure 5.12: Cyclic voltammogram of compound 11F, scan rate 100 mV/s. 
 
 
 
Figure 5.13: Square wave voltammogram of compound 11F, scan rate 20 mV/s. 
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The square wave voltammogram of compound 11F (Figure 5.13) shows three sets of 
defined peaks; the first at 8 mV marked as 1 in the voltammogram, the second at 348 mV 
and the third at 552 mV. The first anodic peak occurs in the potential range of the ‘ghost 
peak’ found in the blank scan.  However there was clear evidence of oxidation occurring 
and therefore this peak was not ignored. Again this experiment was repeated to ensure the 
validity of the peak occurring at 8 mV. 
 
5.3 Comparative Assessment 
By comparing the square wave voltammograms of compounds 11D, 11C and 11F one can 
obtain an improved understanding of the structure-reactivity relationship, namely, the 
importance of the α, β double bond functionality and the effect of ring closure. 
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Figure 5.14: Superimposition of the square wave voltammograms of compounds 11D, 
11C and 11F at a scan rate of 20mV/s. 
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This comparison has presented fascinating results. It is clear by comparing the  
2, 5, 4’-trihydroxy dihydrochalcone 11D (680 mV) with the 4’, 6-dihydroxyflavanone 11F 
(8 mV) that ring closure has significantly lowered the oxidation potential and therefore one 
can expect the flavanone to have a higher antioxidant activity than its corresponding 
dihydrochalcone. The first anodic peak for compound 11C, 2, 5, 4’-trihydroxychalcone, 
proved to have the lowest oxidation potential (-1124 mV). Such a low oxidation potential 
renders 2, 5, 4’-trihydroxychalcone a highly potent antioxidant, with a powerful reducing 
ability. This result proves that the α, β unsaturated double bond has a significant effect on 
the oxidation potential, and therefore the antioxidant activity is significantly enhanced by 
its presence. A study by Rice-Evans et al. found that conjugation between the A- and B-
rings permits a resonance effect of the aromatic nucleus that lends stability to the flavonoid 
radical and is therefore critical in optimizing the phenoxyl radical-stabilizing effect [130]. 
 
In terms of increasing antioxidant activity, the compounds may be arranged as follows:  
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Compound 16F: 6-Hydroxy –2’, 5’-dimethoxy flavanone 
 
 
 
Figure 5.15: Cyclic voltammogram of compound 16F, scan rate 100 mV/s. 
 
 
 
 
 
Figure 5.16: Square wave voltammogram of compound 16F, scan rate 20 mV/s. 
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Figure 5.16 shows the cyclic voltammogram of compound 16F at a scan rate of a 
100mV/s. The square wave voltammogram of compound 16F (Figure 5.16) shows five 
sets of peaks, with four defined peaks in the potential range of 0 – 600 mV. The first 
anodic peak occurs at 36 mV, the second at 188 mV, the third at 396 mV and the fourth at 
560 mV. 
 
Compound 17F: 6-Hydroxy –2’, 4’, 5’-trimethoxy flavanone 
 
 
 
Figure 5.17: Cyclic voltammogram of compound 17F, scan rate 100 mV/s. 
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Figure 5.18: Square wave voltammogram of compound 17F, scan rate 20 mV/s. 
 
 
The square wave voltammogram of compound 17F (Figure 5.18) shows five sets of peaks, 
of which four defined peaks are found in the potential range of 0 – 600 mV. The first 
anodic peak occurs at 24mV, the second at 164 mV, the third at 376 mV and the fourth at 
540 mV. 
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Compound 18F: 5, 7-dihydroxy-2’, 4’, 5’-trimethoxy flavanone  
 
 
 
Figure 5.19: Cyclic voltammogram of compound 18F, scan rate 100 mV/s. 
 
 
 
 
Figure 5.20: Square wave voltammogram of compound 18F, scan rate 20 mV/s 
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The square wave voltammogram of compound 18F (Figure 5.20) shows five sets of peaks, 
with four defined peaks occurring in the potential range of 0 – 600 mV. The first anodic 
peak occurs at -108 mV, the second at 32 mV, the third at 176 mV and the fourth at 852 
mV. 
 
5.4 Comparative Assessment 
By comparing the square wave voltammograms of compounds 16F, 17F and 18F we can 
obtain an improved understanding of the structure-reactivity relationship, namely, what 
effect the addition of methoxy groups on the B-ring have on the oxidation potential. 
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Figure 5.21: Superimposition of square wave voltammogram of compounds 16F, 17F and 
18F. 
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There are clear differences between the voltammograms of the polyhydroxylated and 
polymethoxylated flavonoids. There is an increase in the number of anodic peaks observed 
as well as a remarkable shift of the first anodic peak to a lower region. Therefore we can 
conclude that the addition of methoxy groups on the B-ring makes an improvement on the 
antioxidant ability of such flavanones. The addition of the methoxy group is most likely to 
affect both hydrophobicity and molecular planarity due to steric affects [131]. These 
changes could lead to an increase in antioxidant ability. When comparing compounds 16F 
and 17F, we observe that the addition of a methoxy group at position 4’ has lowered the 
potential of the first anodic peak to some extent. Compound 18F, with two hydroxyl 
groups on the A-ring at positions 5 and 7, has the lowest peak potential and therefore in the 
series studied is the best antioxidant. Therefore it seems a specific ratio of hydroxyl groups 
to methoxy groups might play a role.     
 
In terms of increasing antioxidant activity, the compounds are arranged as follows:  
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Compound 15F:  5, 7, 4’-trihydroxyflavanone (Naringenin) 
 
 
 
Figure 5.22: Cyclic voltammogram of compound 15F, scan rate 100 mV/s. 
 
 
 
 
Figure 5.23: Square wave voltammogram of compound 15F, scan rate 20 mV/s. 
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The square wave voltammogram of compound 15F (Figure 5.23) shows two undefined 
peaks in the range of 500 -1000 mV, with the first peak occurring at 748mV and the 
second at 820mV. 
 
Compound 20F: 5, 7, 4’-trihydroxy-6-isoprenylflavanone 
 
 
Figure 5.24: Cyclic voltammogram of compound 20F, scan rate 100 mV/s. 
 
 
Figure 5.25: Square wave voltammogram of compound 20F, scan rate 20 mV/s. 
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The square wave voltammogram of compound 20F (Figure 5.25) shows on defined peak 
at 688mV. 
 
Compound 19F: 5, 7, 4’-trihydroxy-8-isoprenylflavanone 
 
 
Figure 5.26: Cyclic voltammogram of compound 19F, scan rate 100 mV/s. 
 
 
 
Figure 5.27: Square wave voltammogram of compound 19F, scan rate 20 mV/s. 
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Again we have witnessed a single peak at 676mV in the square wave voltammogram of 
compound 19F (Figure 5.27). 
 
5.5 Comparative Assessment 
By comparing the square wave voltammograms of compounds 15F, 19F and 20F we can 
obtain an improved understanding of the structure-reactivity relationship, namely, what 
effect the addition of a prenyl group, on the A-ring, will have on the oxidation potential. 
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Figure 5.28: Superimposition of square wave voltammogram of compounds 15F, 19F 
and 20F. 
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The voltammograms of the three compounds suggests that the addition of the prenyl group, 
on the A-ring, has had very little effect on the anodic peak potential. There is a very small 
difference in potentials between compounds, 6- prenyl naringenin and  
 8 – prenyl naringenin, with the former having the lower peak potential. The anodic peak 
for compound 14F, Naringenin, is much broader than compounds 19P and 20P; however 
initial oxidation seems to occur in the 665 – 675 mV region which is concurrent with the 
both 6- and 8-Prenyl naringenin. What is clear however is the fact that the oxidation peaks 
for the prenylated naringenins are both more intense and sharper indicating a cleaner 
oxidation pathway and thus a better antioxidant behaviour. 
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CHAPTER 6 
 
6. CONCLUSION 
 
6.1 Synthesis 
12 flavonoid compounds were prepared in order to carry out electrochemical analysis. 
These compounds consist of one dihydrochalcone (11D), two hydroxy chalcones (10C and 
11C), eight flavanones (11F – 18F) and finally two prenylated flavanones (19F and 20F). 
Initial strategies involved finding suitable protecting groups for both the acetophenone and 
benzaldehyde starting materials.   Use of dihydropyran ethers as protecting groups 
produced reasonable yields.  However the products and starting materials were found to 
decompose over time if not protected from exposure to acidic fumes.  The MOM-Br 
reagent, when opened appeared to be decomposing in the container, and subsequently 
produced low yields of MOM-protected benzaldehydes. For these reasons the benzyl 
protecting group was preferred, and subsequent reactions produced good yields and 
products all appeared to be stable. 
 
Claisen Schmidt condensation between the protected hydroxyacetophenones with protected 
hydroxybenzaldehydes proved to be ideal for the formation of chalcone intermediates. 
Chalcone yields improved when the reaction temperature was increased from room 
temperature to 40 oC.  The Chalcone intermediates later underwent oxidative cyclisation, 
using sodium acetate in EtOH to form hydroxyl protected flavanones, as a single product 
in high yields. Acid hydrolysis using HCl was used to demask the pyran protecting groups, 
whereas catalytic hydrogenation proved to be ideal for removing the benzyl protecting 
groups for formation of the pure flavanoids. 
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6.2 Electrochemical analysis 
The study continued with the electrochemical analysis of the prepared flavonoids 
belonging to four flavonoid sub-classes viz., the dihydrochalcones; chalcones; flavanones 
and prenylated flavanones. The antioxidant activity of flavonoids is related to its ability to 
donate electrons to stabilize free radicals and therefore its measured oxidation potential 
renders a useful variable to calculate or postulate its antioxidant activity. The mid-point 
potentials (E½) of the flavanoids were determined by cyclic and square wave voltammetry. 
CV and SWV are advantages because they require small amounts of sample, are easy to 
operate and have short analysis times as compared to other methods. In the case of square 
wave voltammetry, due to the fast analysis time, a better current response was observed 
and therefore less interference was expected on the electrode process as compared to cyclic 
voltammetry. Hence the data from the square wave voltammograms was preferred and 
used to determine the oxidation potentials. For all flavonoids, there was a single reduction 
peak at a potential slightly lower than the first peak potential. It is thus logical to conclude 
that this peak was a result of the reduction of the product of the oxidized functional group 
corresponding to the first oxidation peak potential. 
 
6.2.1 Relationship between antioxidant activity and structure 
6.2.1.1 The effect of substituents 
The type of substituent, number and spatial arrangement is perhaps a greater determinant 
of antioxidant activity than the flavanone backbone alone. Consistent with many other 
studies we have confirmed that addition of hydroxyl groups, on the B-ring, substantially 
influences the antioxidant activity of flavanones. There was no observable change with the 
addition of one hydroxyl group at position 4’, however compound 14F, 4’, 5’-
dihydroxyflavanone showed a large decrease in oxidation potential when compared to the 
4’-hydroxyflananone. We observed that increasing the number of hydroxyl groups on the 
B-ring caused a lower oxidation potential and therefore an increase in antioxidant activity. 
Furthermore it is clear that B-ring hydroxyl substitution is possibly a greater determining 
factor than A-ring hydroxyl substitution. We also noted that a combination of methoxy 
groups on the B-ring and hydroxyl groups on the A ring had increased the antioxidant 
activity of the flavanone backbone, even more so than the flavanones with many hydroxyl 
groups such as Naringenin. The addition of a prenyl group on to Naringenin showed a 
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modest change to the oxidation potential and therefore has had very little effect on the 
antioxidant activity. However these additions were on the A-ring only and future work 
could possibly deal with additions onto the B-ring. 
 
6.2.1.2 The effect the α, β unsaturated double bond and ring closure 
When comparing compounds 2, 5, 4’-trihydroxy dihydrochalcone and  
4’, 6-dihydroxyflavanone, we observe that ring closure has significantly lowered the 
oxidation potential and therefore one could expect the flavanone to have a higher 
antioxidant activity than its corresponding dihydrochalcone. However the 2, 5, 4’-
trihydroxychalcone, which is in the open ring form, and having the α, β unsaturated double 
bond, had the lowest oxidation potential and therefore the greatest antioxidant activity. 
These results suggest that the flavonones, which has a ring C form as well as having the α, 
β unsaturated double bond between C2 and C3, could be the skeletal framework for future 
investigations. 
 
 
 
 
